0001493152-17-014422.txt : 20171208 0001493152-17-014422.hdr.sgml : 20171208 20171208170804 ACCESSION NUMBER: 0001493152-17-014422 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20170831 FILED AS OF DATE: 20171208 DATE AS OF CHANGE: 20171208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Integrated Sciences, Inc. CENTRAL INDEX KEY: 0001138978 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] IRS NUMBER: 593691650 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-109118 FILM NUMBER: 171247748 BUSINESS ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: (206) 617-9797 MAIL ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: TURBINE TRUCK ENGINES INC DATE OF NAME CHANGE: 20010420 10-K 1 form10-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-K

[X]	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended August 31, 2017

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______, 20 ____, to ______, 20_____.

Commission File Number 333-109118

Novo Integrated Sciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

Nevada		59-3691650
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

11120 NE 2nd Street, Suite 200 Bellevue, Washington		98004
(Address of Principal Executive Offices)		(Zip Code)

(206) 617-9797

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: $0.001 par value common stock

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	[ ]	Accelerated filer	[ ]
Non-accelerated filer	[ ]	Smaller reporting company	[X]
(Do not check if a smaller reporting company)
Emerging growth company	[ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes [ ] No [X]

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter, February 28, 2017, was $3,903,769.

There were 202,221,364 shares of the registrant’s $0.001 par value common stock outstanding as of December 6, 2017.

Novo Integrated Sciences, Inc.

Contents

Part I

Item 1.	Business	2
Item 1A.	Risk Factors	9
Item 1B.	Unresolved Staff Comments	9
Item 2.	Properties	9
Item 3.	Legal Proceedings	9
Item 4.	Mine Safety Disclosures	9

Part II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	10
Item 6.	Selected Financial Data	11
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	17
Item 8.	Financial Statements and Supplementary Data	17
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	19
Item 9A.	Controls and Procedures	19
Item 9B.	Other Information	20

Part III

Item 10.	Directors, Executive Officers and Corporate Governance	20
Item 11.	Executive Compensation	23
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	25
Item 13.	Certain Relationships and Related Transactions, and Director Independence	26
Item 14.	Principal Accounting Fees and Services	26
Item 15.	Exhibits, Financial Statement Schedules	27
	Signatures	29

NOVO INTEGRATED SCIENCES, INC.

This Annual Report on Form 10-K and the documents incorporated herein by reference contain forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations, estimates and projections about Novo Integrated Sciences, Inc.’s industry, management beliefs, and assumptions made by management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict; therefore, actual results and outcomes may differ materially from what is expressed or forecasted in any such forward-looking statements.

PART I

ITEM 1. BUSINESS

Business Overview

Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.

We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.

Our strict adherence to public regulatory standards, as well as self-imposed standards of excellence, have allowed us to navigate with ease through the industry’s licensing and regulatory framework. Compliant treatment, data and administrative protocols are managed through a team of highly-trained, certified healthcare and administrative professionals. Novo Healthnet Limited, our wholly owned subsidiary (“NHL”), and its direct and indirect subsidiaries are regulated under the Financial Services Commission of Ontario (“FSCO”). In 2013, NHL received its accreditation from the Commission on Accreditation of Rehabilitation Facilities (“CARF”). Currently, NHL is undergoing the CARF re-accreditation process.

Recent Developments

Share Exchange Agreement

On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

Increase in Size of Board of Directors; Officer and Director Changes

In connection with the Exchange closing, our Board of Directors increased the size of the Board, such that the size of the Board is currently comprised of three members.

On May 9, 2017, in connection with the Exchange, (i) Enzo Cirillo resigned his positions as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, (ii) Christopher David resigned his position as the Company’s Secretary and Treasurer, and (iii) Judith Norstrud resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retained his responsibilities as the Company’s President and as a member of the Company’s Board of Directors.

Also on May 9, 2017, the Board appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, and Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer, effective immediately. Mr. Gaynor is the trustee of MGFT. As a result of the Exchange, MGFT acquired 16,779,740 shares of the Company’s common stock, which represented approximately 8.5% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of MGFT’s stock ownership was $14,094,982, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. Dr. Dalcourt is the President and 50% owner of 1218814. Amanda Dalcourt, NHL’s Chief Executive Officer and Dr. Dalcourt’s spouse, also is a 50% owner of 1218814. As a result of the Exchange, 1218814 acquired 31,881,507 shares of the Company’s common stock, which represented approximately 16.2% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of 1218814’s stock ownership was $26,780,466, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. The value of each of Dr. Dalcourt’s and Ms. Dalcourt’s ownership interests in 1218814’s Company common stock as of May 9, 2017, based on the closing price of the Company’s common stock on May 9, 2017, was $13,390,233.

Change in Fiscal Year End

On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31, but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.

Change in the Company’s Independent Registered Public Accounting Firm

On May 31, 2017, our Board of Directors approved the engagement of AJ Robbins CPA, LLC, and the dismissal of Warren Averett, LLC, as our independent registered public accounting firm.

Business Strategy

Our mission is to build a Canada and U.S. based multi-disciplinary primary healthcare service provider that provides certain high-quality specialized healthcare services and products through the integration of technology and medical science. Key elements of our business strategy include:

	●	Increase Market Share in Canada. We intend to expand our market share in Canada through strategic acquisitions and micro-clinic roll-outs. In addition, we expect to continue increasing our market share in existing eldercare services, occupational therapy services, physiotherapy services and speech language pathology services through network affiliation growth and new contract awards.

	●	Expanding Operations into the United States. We plan to expand into the United States through:

	●	The introduction of a customized version of our multi-disciplinary primary healthcare service model, with emphasis on pain prevention, treatment and management,

	●	The strategic acquisition of targeted U.S. operating clinics in key geographical areas, and

	●	Establishment of strategic corporate alliances with existing healthcare entities allowing us immediate access to their client base. We expect to integrate certain of our specialized multi-disciplinary services and products that are a direct compliment to the existing healthcare related products and services already provided by brand-recognized, established retail entities such as grocers, pharmacies and clinics.

	●	Leveraging our Expertise in the Interface of Technology and Patient Engagement to Introduce our Multi-disciplinary Primary Healthcare Services and Products through “Micro-clinics” Located in Underserved Population Centers. Our expertise allows us to bring our specialized multi-disciplinary primary healthcare services and products to people in urban, rural and remote population centers, rather than relying on the older model of bringing the people to healthcare.

	●	Expanding our Posture, Stride, and Kinetic Body Movement Scanning Technologies and Protocols. When combined with decades of data harvesting and analysis, we believe that these technologies and protocols provide our clinics with the ability to deliver better care, early diagnosis and preventative healthcare strategies.

	●	Continuing to Develop and Expand our Virtual Physician Access System. We expect to continue development and expansion of our virtual physician access system, sometimes referred to in the industry as “telemedicine” or “virtual medicine.” Our telemedicine system provides patients with real-time access to third-party primary care doctors and specialists in most medical disciplines. Telemedicine is transforming all approaches to healthcare by providing ease of access and reduced costs for patients, particularly in areas with limited access to primary care general practitioners and specialists. Unlike other telemedicine platforms in today’s marketplace, our unique advanced telemedicine platform integrates certain medical devices, such as a blood pressure reading device, a derma scope and an ophthalmoscope otoscope, each of which can provide the doctor with real-time diagnostic data, greatly enhancing the doctor’s ability to provide the patient with an accurate diagnosis. Our telemedicine platform is designed with a relatively low-cost structure, which can allow any medical clinic or location affordably to install and utilize our telemedicine platform.

	●	Launching our Exclusive Cannabidiol (“CBD”) Medical Cannabis Product Platform to Include Manufacturing, Sales and Distribution. Our CBD products will be specifically focused on CBD for usage as (i) a treatment aid; (ii) relief for a large array of neurological disorders; and (iii) an alternative option for healthcare providers in place of prescribing opioids to patients. We have established relationships worldwide with low-cost grow and production entities which, when combined with having ownership and control of the end-product manufacturing process, allows us to provide high-quality, low-cost CBD medical cannabis products. Offering our patients access to non-hallucinogenic and non-addictive natural remedies, under required clinical oversight policies and procedures as they relate to medicinal cannabis and CBD, combined with our existing clinic-based treatment protocols allows us to enter this market segment with a unique integration model not readily available in the marketplace.

	●	Launching our Motor Vehicle Accident (“MVA”) Service in Canada. Our MVA service is expected to provide certain occupational therapy, assessment, analysis, rehabilitation, mobility aids and counseling.

	●	Launching our Independent Medical Evaluation (“IME”) Service in Canada. Our IME service will be available for corporate and insurance clients.

Back on Track Physiotherapy and Health Centres

On September 30, 2013, NHL closed a Purchase and Sale of Assets Agreement with Michael Gaynor Physiotherapy Professional Corporation, operating as Back on Track Physiotherapy and Health Centres (“Back on Track”), for all tangible and intangible assets of Back on Track, including four operational physiotherapy clinics located in Ottawa, Ontario, Canada. Since 1994, Back on Track Physiotherapy and Health Centres have been providing in-clinic physiotherapy and multi-disciplinary primary healthcare services including chiropractic services, kinesiology, massage therapy, chiropody/foot care and occupational therapy services. As of November 28, 2017, we operate eight Back on Track Physiotherapy and Health centres in the Ottawa area and eastern Ontario regions.

Novo Peak Health Inc.

On September 16, 2013, Novo Peak Health Inc. (“Novo Peak Health”) was incorporated under the laws of Ontario, Canada, as a wholly owned subsidiary of NHL for the purpose of providing multi-disciplinary primary healthcare services to long-term care and retirement facilities in Ontario, Canada. On September 30, 2013, NHL acquired the assets of Peak Health LTC Inc., an Ontario, Canada corporation formed in 2006, including existing contracts with 20 long-care homes and a community physiotherapy clinic license with the Ministry of Health and Long-Term Care. This acquisition provided the initial foundation for Novo Peak Health’s operational and growth strategy focused on providing rehabilitation, physiotherapy, occupational therapy and assistive devices program (“ADP”) multi-disciplinary primary healthcare services to eldercare patients located at various long-term care homes, retirement homes and community clients across Ontario. Novo Peak Health provides its eldercare patients an integrated approach to rehabilitative strategies and continued education for the residents, their caregivers and the patients’ family members through its two major divisions: physiotherapy (“PT”) and occupational therapy (“OT”).

Novo Peak Health’s proprietary Electronic Rehabilitation Record and Management Reporting (“ERRMR”) software solution provides Novo Peak Health the ability to provide each eldercare facility, of both the PT and OT divisions, with reports that identify cost and optimization possibilities, a wide variety of patient outcome measurements, overall contract effectiveness and much more.

Both PT and OT have similar philosophies, offering an overlap and synchronicity between the divisions. This allows for opportunities where contracts for multi-disciplinary primary healthcare services with one particular division can create contractual opportunities for the other division. The PT division has been in existence since the beginning of Novo Peak Health, and the OT division was formed in April 2017 due to an increase in demand for OT healthcare services at many eldercare facilities.

The Novo Peak Health PT division consists of the following five sectors:

	1.	Long-Term Care Homes (“LTC”) sector - contracts with client homes to provide individualized PT and group exercise classes to the residents living in the homes. Registered physiotherapists are assisted by on-site support personnel to deliver individualized care based on assessed needs. These services are primarily funded by the Ontario Ministry of Health and Long-Term Care (“MOHLTC”). The Novo Peak Health team assists in providing Assistive Device Assessments enabling residents access to varying mobility aides. In addition to providing PT services, our team assists the interdisciplinary team in annual care conferences for residents in the home, education regarding nursing restorative programming, back education, falls prevention and many other subjects related to PT or physical health and wellness. The Novo Peak Health team works together with the interdisciplinary team to help with mandatory coding of the RAI-MDS resident assessment which assists the home in accessing payment from the MOHLTC. Additionally, through Novo Peak Health’s proprietary software, the homes have access to unparalleled reporting solutions to help provide objective and quantitative measures for their Continuous Quality Improvement (“CQI”) program.

	2.	Retirement Homes (“RH”) sector - contracts with client homes to provide individualized PT and group exercise classes to the facilities’ residents. Registered physiotherapists are assisted by the onsite support personnel to deliver individualized care based on assessed needs. These services are partly privately funded and partly funded by the MOHLTC. Similar to the LTC sector, the Novo Peak Health team assists with education of the nursing/interdisciplinary team as well as being able to provide in depth service reports to the homes to measure desired service delivery. In addition to the services above, some of the residents in the retirement homes (or their family members) desire to have an increased level of service and opt to pay for additional private services. This is available on a fee-for-service basis and is most often in the form of individualized PT.

	3.	Community Care Access Centres (“CCACs”) and Home Care sector - now managed by the Local Health Integration Networks (“LHINs”). Contracts with two main “cluster providers” (companies who have direct service contracts with the CCAC/LHIN) funded by the MOHLTC, to provide multi-disciplinary services to patients living in the community, patients living at-home or in a retirement home. Novo Peak Health is sub-contracted by the “cluster provider companies” to provide in-home physiotherapy services and group exercise classes to these clients who cannot access outpatient services due to mobility challenges. Primarily, these patients are elderly while some patients are not elderly but are post-operation” with mobility challenges. This contract is unique to Northeastern Ontario LHIN, which takes care of more than 565,000 people across 400,000 square kilometres and five sub-regions.

	4.	Exercise & Falls Prevention (“EFP”) sector - contracts with two companies who are directly contracted by the MOHLTC to provide exercise and falls prevention classes in the community at large. The delivery of these classes covers three LHINs (Central, Toronto Central and Central East) with an estimated population of 4.4 million people. A new community group exercise class initiative, released in 2013 and funded by the MOHLTC, is delivered by exercise instructors over a 48-week period each year. The goal of these classes is to assist seniors in maintaining an active and healthy lifestyle while still living at home. In addition, another component of the September 2013 MOHLTC initiative is the delivery of fall prevention classes taught by specialized registered providers, such as kinesiologists and physiotherapists, with the assistance of exercise instructors. The goal of these classes is to assess seniors’ general health status, identify defined levels of risk pertaining to balance and falling, and educate seniors about fall prevention through a combination of increased knowledge and teaching exercises designed to improve strength and balance.

	5.	Outpatient Sector (“OP”) sector – two community based clinics for which Novo Peak Health provides outpatient PT services. One of the clinics has been in operation for years and the other is a new start-up, in North Western Ontario, being affiliated with a local hospital/health network. One of the clinics also provides chiropractic services. Both clinics have a component of their services that are funded by the MOHLTC while the remainder of the services in the community based clinics are funded by motor vehicle accident treatment plans, extended health benefits insurance coverage, or private payment. These services are specifically targeted to be delivered to clients who meet the following criteria:

	●	Aged 65 years of age and older or aged 18 years of age and younger, and

	●	Are post-operative, or

	●	Have just been discharged from a hospital, or

	●	Are receiving services from Ontario Disability Services Program (“ODSP”) or Ontario Works.

The Novo Peak Health OT Division consists of two sectors:

Long Term Care Sector - contracts with client homes to provide the following occupational therapy services:

	●	Assessments and interventions to support maintenance & restoration of function related to seating, mobility, positioning for self-care, prevention of pressure ulcers, falls and use of restraints,

	●	Speech language and pathology services, including evaluation and treatment,

	●	Swallowing and eating assessments and interventions, and

	●	Cognitive behavioral assessments and care planning.

Our occupational therapists have specialized training in mobility providing assistive device assessments when required. This service is funded primarily by the MOHLTC.

Retirement Home & Community (“RH&C”) - individual contracts with private payers providing the following services:

	●	Home safety assessments,

	●	Functional assessments,

	●	In-home activities of daily living assessments,

	●	Assessment and completion of applications for assistive devices (mobility aids),

	●	Custom seating & mobility consultations, and

	●	Case management services.

	●	Speech Language and Pathology Services including evaluation and treatment

Novo Dental

On March 31, 2015, NHL completed the formation of a 50/50 joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated under the name Novo Dental. This joint venture was formed for the purpose of providing dental assessments and treatments, as well as preventative dental care and education, for elderly located in long-term care homes and retirement facilities. As required, Novo Dental processes referrals to dentists, oral maxillofacial surgeons and denturists.

Combining the experience and contacts developed by NHL over many years of providing multi-disciplinary primary healthcare services to the aging population along with the over 24-years Sophie Freeman had as a registered dental hygienist, our joint venture is well positioned to best understand the advanced dental services, assessments and education needs of the elderly, including those individuals that are either physically or medically compromised.

Novo Dental provides the following preventive dental hygiene care and assessment services:

	●	Dental/oral assessments - complimentary dental and oral assessments to all residents in Long Term Care. This assessment consists of a thorough intra and extra oral assessment of lymph nodes, lips, tongue, salivary glands, hard and soft palate, teeth and dentures.

	●	Scaling of teeth - Includes removing tartar buildup with appropriate instruments to help maintain health of gums and bone.

	●	Polishing of teeth - includes removing dental plaque and stains to maintain healthy gums.

	●	Fluoride varnishes - provide all necessary cavity-preventative fluoride varnishes such as Duraflor and an assortment of higher concentrated fluoridated toothpaste. Fluoride varnishes are used to help prevent cavities, desensitize teeth and to alleviate thermal sensitivity.

	●	Temporary restorations - provide temporary restorations to alleviate pain and delay the progression of decay. Temporary restorations help maintain resident appearance and ability to masticate.

	●	Professional denture cleanings - includes soaking dentures in a solution and placing them in an ultrasonic bath to remove tartar, plaque and stains without damaging the dentures. Novo Dental also provides professional labeling of dentures.

	●	Oral health education - Novo Dental provides hands-on education to staff on how to effectively and safely provide daily oral hygiene care.

Novo Healthnet Rehab Limited

Novo Healthnet Rehab Limited, a 100% owned Canadian subsidiary of NHL, holds all rental and lease agreements for the Novo affiliates and produces no revenue.

About Our Affiliate Clinics

In order to strengthen our position within the Canadian Preferred Provider Network (“PPN”), we have built a contracted affiliate relationship with over 150 clinics across Canada. The PPN is a network comprised of three major insurance companies and their subsidiaries, totaling 16 insurance companies. PPN member insurance companies in need of specific primary healthcare solutions for their patients send referrals to specific clinics registered through the PPN. We, as one of five major providers to the PPN, receive referrals through the PPN. This subset of business is a continuous source of referrals, from the insurance company payer to the approved group of clinics meeting the insurance companies’ pre-determined set of criteria for what they believe to be an appropriate clinical setting. Affiliate clinics pay us a mix of a flat fee and a percentage based fee upon receipt of a payment for a service referred through the PPN.

The services provided by our affiliate clinics are consistent with the multi-disciplinary primary healthcare services provided by clinics owned by us. While each affiliate clinic may provide additional unique healthcare solutions, in order to strengthen its position in its respective immediate local market, all affiliate clinics must meet certain criteria established by the PPN, so these criteria are consistent among all of our owned and affiliated clinics. Most of our affiliate clinics are located in Ontario. Approximately, 15% of our affiliate clinics are located outside of Ontario, including in Newfoundland, Nova Scotia, New Brunswick and Alberta.

Contracts

Certain contracts held with client homes and client companies follow standard formats, templates and include generally accepted terms of reference. Certain of the main clauses of the NHL contracts for services and other work product contain language intended to (1) clarify which entity is the health information custodian of the medical files (usually held by the client home or company), (2) define release of liability, (3) ensure privacy and confidentiality of proprietary information or private health information, (4) define provisions of worker’s compensation clearance or benefits for employees and/or contractors, (5) detail provisions of value-added items, services or programs, (6) terms and conditions of the contract (often for a set number of years with an option to a renewal option), (7) provide for termination conditions, and (8) invoicing and billing procedures.

Competition

In Canada, the specialized multi-disciplinary primary healthcare service sector in which we operate is highly competitive. With a finite number of patients and clients, companies providing multi-disciplinary primary healthcare services similar to those that we provide are vying for the same contracts, customers and referrals.

Our business strategy includes pursuing selective acquisitions of additional multi-disciplinary primary healthcare providers and clinics in markets that we currently populate as well as new geographic markets. In pursuit of certain acquisitions, we face competition from other for-profit multi-disciplinary primary healthcare providers and clinics that are neither affiliated with nor owned by NHL. We face competition from existing multi-disciplinary primary healthcare providers that offer patients a different path of diagnosis, assessment, treatment, management and rehabilitation healthcare services. We utilize both employee and independent contractor clinicians for delivery of our multi-disciplinary primary healthcare services and are always seeking to attract clinics and clinicians that are qualified to maintain our Company’s reputation for high-quality care and patient satisfaction.

Our ability to effectively compete for patients is impacted by commercial and managed care payor programs that influence patient choice by offering health insurance plans that restrict patient choice of provider. Patients in the markets where we provide our multi-disciplinary primary healthcare services may travel to out-of-market providers to seek medical treatment for a variety of reasons including, but not limited to, the need for services we do not offer or as a result of either a PPN referral or the referral of another clinician. Patients who seek multi-disciplinary primary healthcare services from an out-of-market provider may subsequently shift their preferences to that clinician for future healthcare services.

Employees

As of August 31, 2017, we employed 61 full-time employees. We believe that we maintain a satisfactory working relationship with our employees and have not experienced any labor disputes.

Corporate History

Since inception and through May 9, 2017, the Company’s activities and business operations were limited to raising capital, organizational matters and the implementation of its business plan related to research, development, testing and commercialization of various alternative energy technologies.

On September 5, 2013, NHL was incorporated under the laws of Ontario province, Canada. On September 16, 2013, Novo Peak Health Inc., Novo Assessments Inc. and Novo Healthnet Rehab Limited were formed as Ontario, Canada corporate entities, each wholly owned by NHL. On November 18, 2014, Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, was formed with NHL owning an 80% interest. On March 31, 2015, NHL completed the formation of a 50/50 joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated under the name Novo Dental. On April 1, 2017, NHL purchased assets of Apka Health to expand our community occupational therapy services.

ITEM 1A. RISK FACTORS

Not applicable.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

The Companies’ corporate headquarters are located at 11120 NE 2^nd Street, Suite 200, Bellevue, WA 98004.

ITEM 3. LEGAL PROCEEDINGS

Except as set forth herein, as of the date of this Annual Report on Form 10-K, there are no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which we are a party or which our property is the subject. In addition, none of our officers, directors, affiliates or 5% stockholders (or any associates thereof) is a party adverse to us, or has a material interest adverse to us, in any material proceeding.

The Company is currently involved in litigation in Taiwan, wherein the Company engaged Formosan Brothers, a Taiwan-based law firm, to file a criminal complaint with the Taipei, Taiwan District Prosecutors Office (the “Prosecutor”) seeking criminal charges against the principal partners of ETS, Mr. Chen, Chong-Ping (“Alan Chen”) and Huang, Ren-Ju (“Mr. Huang”) for fraud in connection with their actions related to the Company’s business initiative to commercialize the HPBS technology in Asia.

On December 25, 2015, the Company received a written ruling from the Taiwan District Prosecutor’s Office that it had declined to prosecute Alan Chen and Mr. Huang for criminal fraud.

On January 4, 2016, the Company filed an appeal to the Taiwan High Prosecution Office. On February 1, 2016, the Company’s appeal was granted and the case was returned to the Taiwan District Court Prosecutor with instructions to conduct a new investigation of the facts and evidence. The Company intends to continue to pursue this matter until a final resolution is obtained.

On June 12, 2017, Mr. Chen was indicted and charged with criminal fraud and the Company was informed that Mr. Huang will not be indicted.

On the recommendation of both the Company’s Taiwan attorneys and the judge overseeing the criminal fraud case against Mr. Chen, the Company filed an ancillary civil action against Mr. Chen allowing the judge overseeing the criminal fraud case to initiate a mediation proceeding between the Company and Mr. Chen for a potential financial settlement. Mr. Chen did not appear for an August 1, 2017 mediation hearing but did appear for the subsequent criminal hearing. The defendant pleaded not guilty and the judge notified both parties the case will proceed to trial.

In late August 2017, the Company filed a Confiscation Application with the Taiwan Taipei District Court requesting the prosecutor’s office search for and confiscate any assets the prosecutor can locate in the name of Alan Chen as security for the compensation to the Company pending the criminal trial’s outcome. As of the date of this filing, the Company is awaiting the results of this Confiscation Application.

On November 23, 2017, Mr. Chen and the Company’s legal team appeared for a hearing to determine accepted facts and any additional evidence. The parties are waiting for the next court date to be scheduled.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock is quoted on the OTCQB tier of the OTC Markets Group under the symbol, “NVOS.” The OTC Market is a computer network that provides information on current “bids” and “asks,” as well as volume information.

The following table sets forth the range of high and low closing bid quotations for our common stock for each of the periods indicated as reported by the OTC Markets. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

	Bid Prices
	Low		High
FISCAL 2016

First Quarter (September 1, 2015 through November 30, 2015)	$	0.05	$	0.10
Second Quarter (December 1, 2015 through February 29, 2016)	$	0.03	$	0.036
Third Quarter (March 1, 2016 through May 31, 2016)	$	0.05	$	0.07
Fourth Quarter (June 1, 2016 through August 31, 2016)	$	0.16	$	0.40

FISCAL 2017

First Quarter (September 1, 2016 through November 30, 2016)	$	0.30	$	0.47
Second Quarter (December 1, 2016 through February 28, 2017)	$	0.21	$	0.45
Third Quarter (March 1, 2017 through May 31, 2017)	$	0.41	$	0.77
Fourth Quarter (June 1, 2017 through August 31, 2017)	$	0.203	$	0.55

On December 6, 2017, the closing bid price of our common stock as reported on the OTCQB was $0.46 and there were approximately 542 shareholders of record.

DIVIDENDS

We have not paid any cash dividends on our common or preferred stock and do not anticipate paying any such cash dividends in the foreseeable future. Earnings, if any, will be retained to finance future growth. We may issue shares of our common stock and preferred stock in private or public offerings to obtain financing, capital or to acquire other businesses that can improve our performance and growth. Issuance and or sales of substantial amounts of common stock could adversely affect prevailing market prices in our common stock.

Common Stock

During the year ended August 31, 2017, there was no modification of any instruments defining the rights of holders of the Company’s common stock and no limitation or qualification of the rights evidenced by the Company’s common stock as a result of the issuance of any other class of securities or the modification thereof.

On September 2, 2016, the Company sold 27,777 shares of common stock to 2367416 Ontario, Inc., a Canadian corporation owned by Mr. Cirillo, who at the time was our Interim Chief Executive Officer, Chairman of the Board and more than 10% stockholder (“2367416 Ontario”), for an aggregate purchase price of $15,000 (which represents a per share purchase price of $0.54). This sale occurred prior to the closing of the Exchange. Effective May 9, 2017, Mr. Cirillo resigned as an officer and director of the Company.

On October 17, 2016, the Company sold 35,714 shares of common stock to 2367416 Ontario for an aggregate purchase price of $15,000 (which represents a per share purchase price of $0.42).

On December 9, 2016, the Company sold 76,923 shares of common stock to 2367416 Ontario for an aggregate purchase price of $20,000 (which represents a per share purchase price of $0.26).

On December 21, 2016, the Company sold 115,385 shares of common stock to 2367416 Ontario for an aggregate purchase price of $30,000 (which represents a per share purchase price of $0.26).

On March 8, 2017, the Company sold 33,333 shares of common stock to 2367416 Ontario for an aggregate purchase price of $15,000 (which represents a per share purchase price of $0.45).

All of the above shares were sold in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

ITEM 6. SELECTED FINANCIAL DATA

Not required.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THIS FILING CONTAINS FORWARD-LOOKING STATEMENTS. THE WORDS “ANTICIPATED,” “BELIEVE,” “EXPECT,” “PLAN,” “INTEND,” “SEEK,” “ESTIMATE,” “PROJECT,” “WILL,” “COULD,” “MAY,” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. THESE STATEMENTS INCLUDE, AMONG OTHERS, INFORMATION REGARDING FUTURE OPERATIONS, FUTURE CAPITAL EXPENDITURES, AND FUTURE NET CASH FLOW. SUCH STATEMENTS REFLECT THE COMPANY’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND FINANCIAL PERFORMANCE AND INVOLVE RISKS AND UNCERTAINTIES, INCLUDING, WITHOUT LIMITATION, GENERAL ECONOMIC AND BUSINESS CONDITIONS, CHANGES IN FOREIGN, POLITICAL, SOCIAL, AND ECONOMIC CONDITIONS, REGULATORY INITIATIVES AND COMPLIANCE WITH GOVERNMENTAL REGULATIONS, THE ABILITY TO ACHIEVE FURTHER MARKET PENETRATION AND ADDITIONAL CUSTOMERS, AND VARIOUS OTHER MATTERS, MANY OF WHICH ARE BEYOND THE COMPANY’S CONTROL. SHOULD ONE OR MORE OF THESE RISKS OR UNCERTAINTIES OCCUR, OR SHOULD UNDERLYING ASSUMPTIONS PROVE TO BE INCORRECT, ACTUAL RESULTS MAY VARY MATERIALLY AND ADVERSELY FROM THOSE ANTICIPATED, BELIEVED, ESTIMATED, OR OTHERWISE INDICATED. CONSEQUENTLY, ALL OF THE FORWARD-LOOKING STATEMENTS MADE IN THIS FILING ARE QUALIFIED BY THESE CAUTIONARY STATEMENTS AND THERE CAN BE NO ASSURANCE OF THE ACTUAL RESULTS OR DEVELOPMENTS.

The following discussion and analysis of our financial condition and plan of operations should be read in conjunction with our financial statements and related notes appearing elsewhere herein. This discussion and analysis contains forward-looking statements including information about possible or assumed results of our financial conditions, operations, plans, objectives and performance that involve risk, uncertainties and assumptions. The actual results may differ materially from those anticipated in such forward-looking statements. For example, when we indicate that we expect to increase our product sales and potentially establish additional license relationships, these are forward-looking statements. The words expect, anticipate, estimate or similar expressions are also used to indicate forward-looking statements.

Business Overview

Recent Developments

Share Exchange Agreement

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

Increase in Size of Board of Directors; Officer and Director Changes

In connection with the Exchange closing, our Board of Directors increased the size of the Board, such that the size of the Board is currently comprised of three members.

Change in Fiscal Year End

Change in the Company’s Independent Registered Public Accounting Firm

On May 31, 2017, our Board of Directors approved the engagement of AJ Robbins CPA, LLC, and the dismissal of Warren Averett, LLC, as our independent registered public accounting firm.

For the year ended August 31, 2017 compared to the year ended August 31, 2016

Revenues for the year ended August 31, 2017 were $7,963,045, representing an increase of $784,799, or 10.9%, from $7,178,246 for the same period in 2016. The increase in revenue is principally due to the Company’s entry into new occupational therapy service contracts in January 2017 and the acquisition of Apka Health, Inc. in April 2017.

Cost of revenues for the year ended August 31, 2017 were $4,985,715, representing an increase of $315,100, or 6.7%, from $4,670,615 for the same period in 2016. The increase in cost of revenues is principally due to the increase in revenues. Cost of revenues as a percentage of revenue was 63% for the year ended August 31, 2017 and 65% for same period in 2016. The decrease in cost of revenues as a percentage of revenue is principally due to slightly lower costs.

Operating costs for the year ended August 31, 2017 were $3,090,374, representing an increase of $704,697, or 29.5%, from $2,385,677 for the same period in 2016. The increase in operating costs is attributed to stock based compensation of $252,428 for the year ended August 31, 2017 (there was no stock based compensation for the same period in 2016) as well as an increase in both operating payroll expenses and professional fees.

Interest expense for the year ended August 31, 2017 was $554,657, representing an increase of $31,317, or 6.0%, from $523,340 for the same period in 2016. The increase in interest expense is due to an increase in the aggregate principal amount of interest bearing notes being outstanding during the year ended August 31, 2017 compared to the same period in 2016.

Net loss for the year ended August 31, 2017 was $745,264, representing an increase of $399,086, or 115.3%, from $346,178 for the same period in 2016. The increase in net loss is due to the reasons described above.

Liquidity and Capital Resources

As shown in the accompanying financial statements, for the year ended August 31, 2017 and 2016, the Company has had net losses of $745,264 and $346,178, respectively.

During the year ended August 31, 2017, the Company used cash in operating activities of $810,687 compared to generating cash from operations of $101,388 for the same period in 2016. The principal reason for the decrease is the additional net loss incurred during the year ended August 31, 2017 as compared to the same period in 2016 and the increase in accounts receivable for the year ended August 31, 2017 compared to a decrease in accounts receivable for the same period in 2016.

During the year ended August 31, 2017, the Company used cash in investing activities of $749,530 compared to $462,304 for the same period in 2016. The principal reason for the increase is the payment of deposit acquisitions and changes in other receivables.

During the year ended August 31, 2017, the Company generated cash of $3,107,539 from financing activities compared to $402,207 for the same period in 2016. The principal reason for the increase is the sale of common stock during the year ended August 31, 2017, as discussed below.

On March 8, 2017, the Company sold 33,333 restricted shares of common stock to 2367416 Ontario, Inc. The shares were sold at a price of $0.45 per share, for an aggregate purchase price of $15,000. This sale of 33,333 restricted shares occurred prior to the share exchange as described above. The $15,000 was provided to fund the Company’s ongoing operational and product development expenses. At the time of the sale, Enzo Cirillo was the Company’s Interim CEO, Chairman of the Board and a greater than 10% shareholder of the Company’s common stock, as well as the principal partner of 2367416 Ontario, Inc. Effective May 9, 2017, Mr. Cirillo resigned as an officer and director of the Company. Additionally, with the closing of the Share Exchange Agreement between the Company and Novo Healthnet Limited, Mr. Cirillo is no longer a greater than 10% shareholder of the Company’s common stock.

On May 19, 2017, the Company sold 8,368,500 restricted shares of common stock to an aggregate of 23 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $2,510,550. The $2,510,550 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

On June 20, 2017, the Company sold 2,140,839 restricted shares of common stock to an aggregate of 12 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $642,250. The $642,250 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

On August 24, 2017, the Company sold 779,202 restricted shares of common stock to an aggregate of three accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $233,760. The $233,760 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

We believe that the following critical policies affect our more significant judgments and estimates used in preparation of our financial statements.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Noncontrolling Interest

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Revenue Recognition

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Stock-Based Compensation

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

Basic and Diluted Earnings Per Share

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,860,000 options/warrants outstanding as of August 31, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,240,844 and $1,277,449 at August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

New Accounting Pronouncements

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15 on the Company’s financial statements and disclosures.

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Recent accounting pronouncements issued by the FASB, the AICPA and the Securities and Exchange Commission did not or are not believed by management to have a material effect on the Company’s financial statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

Consolidated Financial Statements

Contents

	Page
Financial Statements:

Report of Independent Registered Public Accounting Firm	F-1

Consolidated Balance Sheets as of August 31, 2017 and 2016	F-2

Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended August 31, 2017 and 2016	F-3

Consolidated Statement of Stockholders’ Deficit for the Years Ended August 31, 2017 and 2016	F-4

Consolidated Statements of Cash Flows for the Years Ended August 31, 2017 and 2016	F-5

Notes to Consolidated Financial Statements	F-6

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and

Stockholders of Novo Integrated Sciences, Inc.

We have audited the accompanying consolidated balance sheets of Novo Integrated Sciences, Inc and Subsidiaries (collectively “the Company”) as of August 31, 2017 and 2016, and the related consolidated statements of operations and comprehensive loss, changes in stockholders’ deficit, and cash flows for the years then ended. The Company’s management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Novo Integrated Sciences, Inc. as of August 31, 2017 and 2016, and the consolidated results of their operations and their cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

/s/ AJ Robbins CPA LLC
Denver, Colorado

December 6, 2017

aj@ajrobbins.com

3773 Cherry Creek North Drive, Suite 575 East, Denver, Colorado 80209

(B)303-331-6190 (M)720-339-5566 (F)303-845-9078

F-1

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONSOLIDATED BALANCE SHEETS

As of August 31, 2017 and 2016

	August 31, 2017			August 31, 2016
ASSETS
Current Assets:
Cash and cash equivalents	$	1,896,572		$	110,315
Accounts receivable, net		1,128,898			785,780
Other receivables		372,024			735,330
Due from related parties		-			784,833
Prepaid expenses and other current assets		252,536			156,221
Total current assets		3,650,030			2,572,479

Property and equipment, net		302,951			318,718
Acquisition deposits		1,162,009			-
Goodwill		399,400			-

TOTAL ASSETS	$	5,514,390		$	2,891,197

LIABILITIES AND DEFICIT

Current Liabilities:
Accounts payable	$	1,703,342		$	2,035,328
Accrued expenses		341,657			235,420
Accrued interest (principally to related parties)		403,119			832,766
Due to related parties		1,812,613			1,838,592
Notes payable, current portion		13,171			147,517
Debentures, related parties		-			4,878,714
Total current liabilities		4,273,902			9,968,337

Debentures, related parties		5,114,327			-
Notes payable, net of current portion		414,351			11,580
TOTAL LIABILITIES		9,802,580			9,979,917

Commitments and contingencies (Note 10)		-			-

DEFICIT
Novo Integrated Sciences, Inc.
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2017 and 2016					-
Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 167,797,406 shares issued and outstanding at August 31, 2017 and 2016		201,837			92
Additional paid-in capital		3,381,643
Other comprehensive income		1,240,844			1,277,449
Accumulated deficit		(9,091,977	)		(8,353,593	)
Total Novo Integrated Sciences, Inc. stockholders’ deficit		(4,267,653	)		(7,076,052	)
Noncontrolling interest		(20,537	)		(12,668	)
Total deficit		(4,288,190	)		(7,088,720	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	5,514,390		$	2,891,197

The accompanying footnotes are an integral part of these consolidated financial statements.

F-2

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

For the Years Ended August 31, 2017 and 2016

	Years Ended
	August 31, 2017			August 31, 2016

Revenues	$	7,963,045		$	7,178,246

Cost of revenues		4,985,715			4,670,615

Gross profit		2,977,330			2,507,631

Operating expenses:
Selling expenses		59,026			25,610
General and administrative expenses		3,031,348			2,360,067
Total operating expenses		3,090,374			2,385,677

Income (loss) from operations		(113,044	)		121,954

Non operating income (expense)
Interest income		34,139			55,208
Interest expense		(554,657	)		(523,340	)
Total other income (expense)		(520,518	)		(468,132	)

Loss before income taxes		(633,562	)		(346,178	)

Income tax expense		111,702			-

Net loss	$	(745,264	)	$	(346,178	)

Net loss attributed to noncontrolling interest		(6,880	)		(5,649	)

Net loss attributed to Novo Integrated Sciences, Inc.	$	(738,384	)	$	(340,529	)

Comprehensive loss:
Net loss		(745,264	)		(346,178	)
Foreign currency translation gain (loss)		(36,605	)		(54,715	)
Comprehensive loss	$	(781,869	)	$	(400,893	)


Weighted average common shares outstanding - basic and diluted		177,675,415			167,797,406

Net loss per common share - basic and diluted	$	(0.00	)	$	(0.00	)

The accompanying footnotes are an integral part of these consolidated financial statements.

F-3

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT

For the Years Ended August 31, 2017 and 2016

														Total
					Additional			Other						Novo
	Common Stock				Paid-in			Comprehensive			Accumulated			Stockholders'			Noncontrolling			Total
	Shares		Amount		Capital			Income			Deficit			Deficit			Interest			Deficit
Balance, August 31, 2015		167,797,406	$	92	$	-		$	1,332,164		$	(8,012,884	)	$	(6,680,628	)	$	(7,089	)	$	(6,687,717	)

Foreign currency translation loss		-		-		-			(54,715	)		-			(54,715	)		(110	)		(54,825	)
Net loss		-		-		-			-			(340,709	)		(340,709	)		(5,469	)		(346,178	)

Balance, August 31, 2016		167,797,406		92		-			1,277,449			(8,353,593	)		(7,076,052	)		(12,668	)		(7,088,720	)

Common stock issued in connection with reverse merger transaction		22,751,307		190,457		(183,553	)		-			-			6,904			-			6,904
Common stock issued for cash		11,288,541		11,288		3,375,272			-			-			3,386,560			-			3,386,560
Offering costs		-		-		(62,504	)		-			-			(62,504	)		-			(62,504	)
Fair value of vested stock options		-		-		252,428			-			-			252,428			-			252,428
Foreign currency translation gain		-		-		-			(36,605	)		-			(36,605	)		(989	)		(37,594	)
Net loss		-		-		-			-			(738,384	)		(738,384	)		(6,880	)		(745,264	)

Balance, August 31, 2017		201,837,254	$	201,837	$	3,381,643		$	1,240,844		$	(9,091,977	)	$	(4,267,653	)	$	(20,537	)	$	(4,288,190	)

The accompanying footnotes are an integral part of these consolidated financial statements.

F-4

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended August 31, 2017 and 2016

	Years Ended
	August 31, 2017			August 31, 2016

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(745,264	)	$	(346,178	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation		67,776			72,586
Fair value of vested stock options		252,428
Changes in operating assets and liabilities:
Accounts receivable		(289,316	)		412,216
Prepaid expenses and other current assets		(84,161	)		9,321
Accounts payable		(412,877	)		(152,134	)
Accrued expenses		89,937			(233,300	)
Accrued interest		310,790			338,877
Net cash provided by (used in) operating activities		(810,687	)		101,388

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and equipment		(38,238	)		(54,982	)
Amounts loaned for other receivables		-			(407,322	)
Repayments of other receivables		378,098			-
Deposit paid for acquisition		(1,101,639	)		-
Cash acquired in reverse merger transaction		12,249			-
Net cash used in investing activities		(749,530	)		(462,304	)


CASH FLOWS FROM FINANCING ACTIVITIES:
Advances (repayments) to related parties		(85,063	)		466,291
Proceeds from the sale of common stock		3,386,560			-
Offering cost paid		(62,504	)		-
Payments on notes payable		(131,454	)		(64,084	)
Net cash provided by financing activities		3,107,539			402,207

Effect of exchange rate changes on cash and equivalents		238,935			945

NET INCREASE IN CASH AND CASH EQUIVALENTS		1,786,257			42,236

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		110,315			68,079

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	1,896,572		$	110,315

CASH PAID FOR:
Interest	$	186,618		$	177,271
Income taxes	$	-		$	-

SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:
Note payable issued for purchase of assets	$	375,450		$	-

The accompanying footnotes are an integral part of these consolidated financial statements.

F-5

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Note 1 - Organization and Basis of Presentation

Organization and Line of Business

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.

Basis of Presentation

The accompanying consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).

F-6

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Foreign Currency Translation

The accounts of the Company are maintained in CAD. The accounts of the Company are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:

	August 31, 2017		August 31, 2016

Period end: CAD to USD exchange rate	$	0.7988	$	0.7620
Average period: CAD to USD exchange rate	$	0.7573	$	0.7543

Note 2 – Summary of Significant Accounting Policies

Use of Estimates

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

Accounts Receivable

Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of August 31, 2017 and 2016, the allowance for uncollectible accounts receivable was $507,636 and $508,161 respectively.

F-7

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Property and Equipment

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

Leasehold improvements	5 years
Clinical equipment	5 years
Computer equipment	3 years
Office equipment	5 years
Furniture and fixtures	5 years

Long-Lived Assets

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the discounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at August 31, 2017 and 2016, the Company believes there was no impairment of its long-lived assets.

Goodwill

Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $399,400 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.

Acquisition Deposits

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,162,009.

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

F-8

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement.

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

As of August 31, 2017 and 2016, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Income Taxes

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian dollar. Translation gains of $1,240,844 and $1,277,449 for the years ended August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

F-9

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Statement of Cash Flows

Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

Recent Accounting Pronouncements

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

F-10

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Note 3 – Related Party Transactions

Due to related parties

Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.

Note 4 – Other Receivables

Other receivables at August 31, 2017 and 2016 consisted of the following:

	2017		2016
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; was due on November 15, 2016.	$	39,940	$	38,099

Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.		299,550		285,750

Advance to corporation; non-interest bearing; unsecured; payable upon demand		-		381,000

Advance to corporation; non-interest bearing; unsecured; payable upon demand		32,534		30,481
Total other receivables	$	372,024	$	735,330

F-11

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Note 5 – Property and Equipment

Property and equipment at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Leasehold Improvements	$	329,985		$	310,111
Clinical equipment		177,514			147,429
Computer equipment		21,020			8,575
Office equipment		24,319			22,780
Furniture and fixtures		18,218			17,379
		571,056			506,274
Accumulated depreciation		(268,105	)		(187,556	)
Total	$	302,951		$	318,718

Depreciation expense for the years ended August 31, 2017 and 2016 was $67,776 and $72,586, respectively.

Note 6 – Notes Payable

Notes payable at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Notes payable to five individuals; accrues interest at 12% per annum; secured by assets of the Company; due May 29, 2016. These notes were fully repaid.	$	-		$	91,439

Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017.		7,134			47,636

Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.		399,400			-

Notes payable to financial institution; accrues interest at 6% per annum; monthly principal and interest payment of $608; unsecured; due April 8, 2019.		20,988			20,022
		427,522			159,097
Current portion		(13,171	)		(147,517	)
Long-term portion	$	414,351		$	11,580

Aggregate future maturities of notes payable as of August 31, 2017 are as follows:

Years ending August 31:
2018	$	13,171
2019		414,351
	$	427,522

Note 7 – Debentures, related parties

On September 30, 2013, the Company issued five debentures totaling $5,114,327 (CAD$6,402,512) at August 31, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019. On December 5, 2017, the debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value plus any interest or fees owed to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

F-12

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

Note 8 – Stockholders’ Deficit

Convertible preferred stock

The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. As of August 31, 2017 and 2016 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.

Common stock

The Company has authorized 499,000,000 shares of $0.001 par value common stock. As of August 31, 2017 and 2016 there were 201,837,254 and 167,797,406 common shares issued and outstanding, respectively.

During the year ended August 31, 2017 the Company issued:

	●	22,751,307 shares of common stock in connection with the reverse merger transaction; and

	●	11,288,541 shares of common stock for cash proceeds of $3,386,560.

Stock Options and Warrants

On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2016		-
Transfer from reverse merger transactions		6,610,000	$	0.24
Granted		1,250,000	$	0.42
Forfeited		-
Exercised		-
Outstanding, August 31, 2017		7,860,000	$	0.266		3.53	$	660,000
Exercisable, August 31, 2017		6,860,000	$	0.258		3.34	$	660,000

F-13

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

The exercise price for options/warrants outstanding at August 31, 2017:

Outstanding				Exercisable
Number of				Number of
Options/		Exercise		Options/		Exercise
Warrants		Price		Warrants		Price
	5,500,000	$	0.16		5,500,000	$	0.16
	1,000,000		0.32		-		0.32
	100,000		0.50		100,000		0.50
	1,000,000		0.62		1,000,000		0.62
	250,000		0.80		250,000		0.80
	10,000		2.00		10,000		2.00
	7,860,000				6,860,000

For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $252,428 during the year ended August 31, 2017. At August 31, 2017, the unamortized stock option expense was $381,585.

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate		1.5%
Expected life of the options		2.5 years
Expected volatility		323%
Expected dividend yield		0%

Note 9 – Income Taxes

The Company’s Canadian subsidiaries are subject to the income tax laws of the Province of Ontario and the country of Canada.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A full valuation allowance is established against all net deferred tax assets as of August 31, 2017 and 2016 based on estimates of recoverability. While the Company has optimistic plans for its business strategy, it determined that such a valuation allowance was necessary given the current and expected near term losses and the uncertainty with respect to its ability to generate sufficient profits from its business model.

Income tax expense for the years ended August 31, 2017 and 2016 is a follows:

	2017		2016

Current taxes:
Federal	$	-	$	-
State		-		-
Foreign		111,702		-
		111,702		-
Deferred taxes:
Federal		-		-
State		-		-
Foreign		-		-
		-		-

Total income tax expense	$	111,702	$	-

F-14

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

A reconciliation of the differences between the effective and statutory income tax rates are as follows:

Year Ended August 31, 2017

	Canada					United States					Total

Combined statutory tax rate				39.0	%				40.0	%

Pretax loss	$	(257,900	)			$	(375,662	)			$	(699,551	)

Expected income tax expense (benefit)		(100,581	)	-39.0	%		(150,265	)	-40.0	%		(276,582	)
Income tax from subsidiaries not part of consolidated return		111,702		43.3	%		-		0.0	%		111,702
Stock based compensation		-		0.0	%		100,971		26.9	%		100,971
Change in valuation allowance		100,581		39.0	%		49,294		13.1	%		175,611
	$	111,702		43.3	%	$	-		0.0	%	$	111,702		17.6	%

Year Ended August 31, 2016

	Canada					United States				Total

Combined statutory tax rate				39.0	%			40.0	%

Pretax loss	$	(346,178	)			$	-			$	(346,178	)

Expected income tax expense (benefit)		(135,009	)	-39.0	%						(135,009	)
Change in valuation allowance		135,009		39.0	%						135,009
	$	-		0.0	%	$	-	0.0	%	$	-		0.0	%

At August 31, 2017 and 2016, the significant components of the deferred tax assets are summarized below:

	2017			2016
Deferred income tax asset
Net operating loss carryforwards	$	1,856,218		$	1,391,467
Total deferred income tax asset		1,856,218			1,391,467
Less: valuation allowance		(1,856,218	)		(1,391,467	)
Total deferred income tax asset	$	-		$	-

The valuation allowance for the years ended August 31, 2017 and 2016 increased by $464,751 and $132,876, respectively, as a result of the Company generating additional net operating losses and additional net operating losses resulting from the merger transaction.

The Company has recorded as of August 31, 2017 a valuation allowance of $1,856,218, as it believes that it is more likely than not that the deferred tax assets will not be realized in future years. Management has based its assessment on the Company’s lack of profitable operating history.

The Company conducts an analysis of its tax positions and has concluded that it has no uncertain tax positions as of August 31, 2017 and 2016.

F-15

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended August 31, 2017 and 2016

The Company has net operating loss carry-forwards of approximately $738,000 and $3,887,000 in the United States and Canada, respectively. The use of the net operating losses in the United States may be significantly limited due to Internal Revenue Code section 382. The 2017, 2016 and 2015 tax years are still subject to audit.

Note 10 – Acquisition of Assets

During the year ended August 31, 2017, the Company acquired certain assets in exchange for a note payable of $399,400 (CAD$500,000) at April 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

Note 11 – Commitments and Contingencies

Litigation

The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of August 31, 2017, results of operations, cash flows or liquidity of the Company.

Leases

The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $796,745 and $763,339 for the years ended August 31, 2017 and 2016, respectively.

Future minimum annual payments under operating lease agreements for fiscal years ending August 31 are as follows:

Years ending August 31:
2018	$	377,830
2019		292,778
2020		187,985
2021		169,376
2022		108,793
Thereafter		54,902
	$	1,191,664

Note 12 – Subsequent Events

On September 18, 2017, an independent consultant was granted 120,000 stock options of the Company’s common stock with an exercise price of $0.40. Of these, 60,000 options vest on September 18, 2017 and 60,000 options vest on March 18, 2018.

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $5,114,327 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see financial note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.

On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

F-16

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Dismissal of Independent Registered Accounting Firm

On May 31, 2017, the Company’s Board of Directors terminated the engagement of Warren Averett, LLC (“Warren Averett”) as the Company’s independent registered accounting firm.

Warren Averett’s reports on the Company’s financial statements for the fiscal years ended December 31, 2016 and 2015 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. Furthermore, during the Company’s two most recent fiscal years and through May 31, 2017, there have been no disagreements with Warren Averett on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to Warren Averett’s satisfaction, would have caused Warren Averett to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial statements for such periods.

Except as set forth below, for the years ended December 31, 2016 and 2015 and through May 31, 2017, there were no “reportable events” as that term is described in Item 304(a)(1)(v) of Regulation S-K. In connection with its audit of the Company’s financial statements for the years ended December 31, 2016 and 2015, Warren Averett reported the existence of a material weakness in the Company’s internal control over financial reporting to the Company’s Board of Directors. The ineffectiveness of the Company’s internal control over financial reporting was due to the following material weakness which the Company identified in its internal control over financial reporting: a lack of formalized controls and procedures as well as a lack of segregation of duties, as well as the absence of an independent audit committee chair, resulting from the Company’s limited resources.

Engagement of New Independent Registered Accounting Firm

On May 31, 2017, the Company’s Board of Directors appointed AJ Robbins CPA, LLC (“AJ Robbins”) as the Company’s new independent registered accounting firm. During the Company’s two most recent fiscal years and through May 31, 2017, neither the Company nor anyone acting on the Company’s behalf consulted AJ Robbins with respect to any of the matters or reportable events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K.

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company’s President and Principal Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of August 31, 2017. Based upon such evaluation, the President and Principal Financial Officer have concluded that, as of August 31, 2017, the Company’s disclosure controls and procedures were not effective as required under Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rue 13a-15(f) and 15d-15(f) of the Exchange Act) of the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Management, under the supervision of the Company’s President and Principal Financial Officer, conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in 2013 Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was not effective as of August 31, 2017 under the criteria set forth in the 2013 Internal Control – Integrated Framework.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has determined that a material weakness exists due to a lack of segregation of duties. Currently, management contracts with an outside certified public accountant to assist the Company with preparation of its filings required pursuant to the Exchange Act.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the fourth fiscal quarter ended August 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Set forth below is certain information concerning the directors and executive officers of the Company.

Name	Age	Position

Pierre Dalcourt	47	Chairman of the Board of Novo Integrated Sciences, Inc.

Christopher David	58	Principal Executive Officer and Director of Novo Integrated Sciences, Inc.

Klara Radulyne	40	Principal Financial Officer of Novo Integrated Sciences, Inc.

Michael Gaynor	51	Treasurer, Secretary and Director of Novo Integrated Sciences, Inc.

Amanda Dalcourt	46	Chief Executive Officer of Novo Healthnet Limited

Mr. Dalcourt, our Chairman of the Board, is the spouse of Amanda Dalcourt, Chief Executive Officer of NHL. There are no other family relationships among our directors and executive officers.

Biographies

Dr. Pierre P. Dalcourt, D.C. In connection with the closing of the Share Exchange Agreement on May 9, 2017, Dr. Dalcourt was appointed to the Company’s Board of Directors and approved as the Company’s Board Chairman. As a chiropractic business owner, with a core focus and passion serving the masses with a patient centered model, Dr. Dalcourt has had great success creating scalable businesses and high-volume practices combining the wellness approach with sound science. Dr. Dalcourt is a professional health coach and speaker on various stages across North America, as well as a best-selling author having co-written several books on chiropractic, health and self-improvement.

In 1994, Dr. Dalcourt graduated Magna Cum Laude from Canadian Memorial Chiropractic College, Toronto, Ontario. He is a certified acupuncturist, having received his certification from the Medecina Alternativa Institute of Sri Lanka.

Mr. Christopher David. Mr. David was appointed the Company’s Secretary, Treasurer and a Board Director on August 13, 2014. On May 10, 2015, Mr. David was appointed as the Company’s President. Effective May 9. 2017, Mr. David resigned as the Company’s Secretary and Treasurer while maintaining his roles and responsibilities as the Company’s President and a member of the Board of Directors.

Mr. David has been a private venture investor for 23 years in both private and public companies. In addition, Mr. David has been an advisor on operational, internal control, marketing and finance matters to numerous small and medium size businesses in the pharmaceutical, bio-tech, television-movie media, real-estate, technology and industrial commodity industries. Mr. David had been a shareholder of the Company for over 5 years prior to assuming his duties as Secretary, Treasurer and Director of the company in August 2014. Prior to Mr. David professional business career, he retired from the U S Navy officer ranks in 1994. Mr. David holds a BA from University of Washington.

Ms. Klara Radulyne, CPA CGA. Ms. Radulyne has served as our Principal Financial Officer since May 9, 2017. Additionally, Ms. Radulyne is the Director of Finance for NHL, managing all accounting and finance functions.

In 2000, Ms. Radulyne acquired her Masters Degree in Accounting and Corporate Valuation from Corvinus University, Budapest, Hungary and immediately commenced her accounting career as a management accountant in a Hungarian utilities industry company. Ms. Radulyne moved to Canada and began her employment with NHL in 2006 as a Junior Accountant. Ms. Radulyne earned her Canadian CGA designation in 2010 and Canadian CPA designation in 2014.

Mr. Michael Gaynor, BScPT, FCAMPT. Mr. Gaynor has served as the Company’s Secretary, Treasurer and a member of the Company’s Board of Directors since May 9, 2017. For over 28 years as a healthcare professional and business owner Mr. Gaynor has delivered a healthcare model that includes best practices and innovation to meet various needs for both his community and his patients. At the core of Mr. Gaynor’s mission is building strong relationships, trust, and rapport which cultivates long-term partnerships, alliances, collaboration, forward momentum and positive results.

In 1994, Mr. Gaynor founded Back on Track Physiotherapy & Health Centres which has grown into eight multidisciplinary health and wellness centres of excellence in the Ottawa Canada marketplace. During these 23 years, Mr. Gaynor has proven his capacity to simultaneously practice his healthcare professional trade while also being responsible for business development, marketing and operations. The Back on Track expansion model has been centered on organic business development combined with turnarounds and transitional growth via clinic acquisitions and strategic partnerships.

In 2013, Back on Track was acquired by NHL. Mr. Gaynor joined the NHL team as managing partner and Chief Operating Officer. Currently, Mr. Gaynor is an integral contributor to NHL’s strategic planning, ongoing growth and business development.

Mr. Gaynor graduated from Queen’s University in 1989 with a Bachelor of Science in Physical Therapy. Mr. Gaynor has undertaken numerous post graduate studies in a variety of areas including manual therapy, orthopaedics, sports medicine, rehabilitation exercise, acupuncture, as well as practice management and business development, and is committed to the continuing education process. In 1999, as a Fellow of the Canadian Academy Manipulative Physiotherapists (CAMPT), Mr. Gaynor received his Diploma of Advanced Manual & Manipulative Physiotherapy from the Canadian Physiotherapy Association (CPA). He has been an assistant instructor in post-graduate studies for physiotherapists within the Orthopedic Division of the CPA and was the former president of the national capital district of the CPA’s orthopedic division.

Amanda Dalcourt, Reg PT, Dip MDT. Ms. Dalcourt has served as NHL’s Chief Executive Officer since 2015. Ms. Dalcourt is a registered physiotherapist and ADP authorizer with a post-graduate Diploma in Mechanical Diagnosis and Therapy and over 20 years of clinical experience. As Co-Founder and Chief Executive Officer of NHL and Novo Peak Health, Inc., Ms. Dalcourt has been instrumental in the development of client-centered diagnostic, rehabilitative and treatment programs for in-clinic, long-term care and retirement home patients in communities throughout Ontario, Canada. In 2011, Ms. Dalcourt was named Northern Ontario Business Association’s Entrepreneur of the Year. She has co-authored five books and maintains her certifications as a physiotherapist.

CODE OF ETHICS

We have adopted a code of ethics meeting the requirements of Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code of ethics.

ITEM 11. EXECUTIVE COMPENSATION

The following table summarizes all compensation earned by Mr. David, our President, and Ms. Dalcourt, Chief Executive Officer of NHL, and Enzo Cirillo, our former Interim Chief Executive Officer (collectively, our “Named Executive Officers”).

2017 SUMMARY COMPENSATION TABLE

Name and Principal Position	Fiscal Year Ended August 31,	Salary			Bonus		Stock Awards		Option Awards			All Other Compensation		Total
Christopher David	2017	$	26,000		$	0	$	0		$ 551,973	(1)	$	0	$	577,973
President	2016	$	0		$	0	$	0	$	30,000		$	0	$	30,000

Amanda Dalcourt	2017	$	112,849	(2) (3)	$	0	$	0	$	0		$	0	$	112,849
Chief Executive Officer of Novo Healthnet Limited	2016	$	109,195	(2) (4)	$	0	$	0	$	0		$	0	$	109,195

Enzo Cirillo	2017	$	0		$	0	$	0	$	0		$	0	$	0
Former Interim Chief Executive Officer (5)	2016	$	0		$	0	$	0	$	0		$	0	$	0

(1)	Represents the aggregate grant date fair value amount attributable to an option grant. On April 28, 2017, the Board granted Mr. David an option to purchase 750,000 shares of our common stock at an exercise price of $0.62. The option, which has a 5-year term expiring April 28, 2022, vested upon grant. See Note 8 to our audited financial statements included elsewhere herein for assumptions used to determine the aggregate grant date fair value of the option grant.
(2)	Ms. Dalcourt’s salary consists of a management consulting fee, and a professional fee for physiotherapy services provided to patients.
(3)	Represents $102,690 in management consulting fees, and $10,159 for professional physiotherapy services.
(4)	Represents $76,713 in management consulting fees, and $32,482 for professional physiotherapy services.
(5)	Mr. Cirillo ceased to be an executive officer on May 9, 2017.

On February 19, 2016, the Company entered into a Future Services Agreement (the “Future Services Agreement”) with Mr. David regarding his services as a President, Secretary and Treasurer. The Future Services Agreement was set to terminate on December 31, 2017. Pursuant to the terms of the Future Services Agreement, the Company agreed to grant Mr. David an option to purchase 1,000,000 shares of common stock at a purchase price of $0.16 per share, 50% of which vested upon execution of the agreement and 50% of which vested on the first anniversary of the grant date, February 19, 2017. The option expire five years from that date.

On July 12, 2017, Mr. David and the Company entered into a six-month Employment Agreement (the “Employment Agreement”) with Mr. David regarding his services as our President. This Employment Agreement replaces the Future Services Agreement, dated February 19, 2016. The Employment Agreement provides that Mr. David will receive compensation in the form of (1) a monthly salary of $8,000; and (2) a grant to Mr. David a 5-year option to purchase 1,000,000 shares of the Company’s restricted common stock at an exercise price of $0.32 per share. The option will vest on July 12, 2018 and expire on July 12, 2022.

OUTSTANDING EQUITY AWARDS AT AUGUST 31, 2017

	Option Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)		Option Exercise Price ($)		Option Expiration Date
Christopher David		1,500,000		0		0	$	0.16		6/29/20
		1,000,000		0		0	$	0.16		2/19/21
		750,000		0		0	$	0.62		4/28/22
		0		1,000,000		0	$	0.44		7/12/22

Amanda Dalcourt		0		0		0		0		0

Enzo Cirillo (1)		1,500,000		0		0	$	0.16		6/29/20

(1)	Mr. Cirillo ceased to be an executive officer on May 9, 2017.

DIRECTOR COMPENSATION

Directors receive no compensation for serving on the Board.

The following table summarizes compensation paid to all of our non-employee directors:

Name

Fees
Earned
or Paid
in
Cash
($)

Stock
Awards
($)

Option
Awards
($)

Non-Equity
Incentive Plan
Compensation
($)

Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings
($)

All Other
Compensation
($)

Total
($)

not applicable

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

EXISTING EQUITY COMPENSATION PLAN INFORMATION

The table below shows information with respect to all of our equity compensation plans as of August 31, 2017.

Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)		Weighted- average exercise price of outstanding options, warrants and rights (b)		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)

Equity compensation plans approved by security holders		0	$	0.00		4,987,500	(1)
Equity compensation plans not approved by security holders		0	$	0.00		0

(1) This represents the number of shares of common stock issuable pursuant to the Company’s 2015 Incentive Compensation Plan (the “2015 Plan”). Because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the 2015 Plan are no longer registered under the Exchange Act, the Company does not intend to issue any additional grants under the 2015 Plan.

On September 8, 2015, the Company adopted the 2015 Plan, which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the 2015 Plan are no longer registered under the Exchange Act, the Company does not intend to issue any additional grants under the 2015 Plan.

PRINCIPAL STOCKHOLDERS

The following table sets forth as of November 25, 2017 certain information with respect to the beneficial ownership of the Company’s Common Stock by:

	●	each of the Named Executive Officers and directors,

	●	all executive officers and directors as a group, and

	●	each person known by the Company to beneficially own more than 5% of the Company’s Common Stock based on certain filings made under Section 13 of the Exchange Act.

All such information provided by the stockholders who are not executive officers or directors reflects their beneficial ownership as of the dates specified in the relevant footnotes to the table. The percent of shares beneficially owned is based on 201,837,254 shares issued and outstanding as of November 25, 2017. Unless otherwise indicated, the owners have sole voting and investment power with respect to their respective shares.

Name and Address of Beneficial Owner	Number of Shares Beneficially Owned			Percentage of Outstanding Common Stock Owned
Named Executive Officers and Directors:
Christopher David		4,103,100	(1)		2.0	%
Amanda Dalcourt		31,881,507	(2)		15.8	%
Enzo Cirillo (3)		15,431,276	(4)		7.6
Pierre Dalcourt		31,881,507	(2)		15.8
Michael Gaynor		16,779,740	(5)		8.3
All directors and executive officers as a group (5 persons)		52,764,347	(6)		25.7	%
5% Stockholders:
ALMC-ASAP Holdings, Inc.		119,386,158	(7)		59.1	%

(1)	Includes 3,250,000 shares that may be acquired upon exercise of vested options.
(2)	Represents shares owned by 1218814 Ontario Inc., which is 50% owned by Pierre Dalcourt, the Company’s Chairman of the Board, and 50% owned by Amanda Dalcourt, NHL’s Chief Executive Officer. 1218814 Ontario Inc.’s shares are held by the Dalcourt Family Trust. Mr. Dalcourt and Ms. Dalcourt are co-trustees of the Dalcourt Family Trust and share voting and depository power over these shares.

(3)	Mr. Cirillo ceased to be an executive officer of the Company on May 9, 2017.
(4)	Includes 13,349,776 shares owned by 2367416 Ontario Inc., which is wholly owned by Mr. Cirillo. Mr. Cirillo has voting and depository power over these shares. Also includes 1,500,000 shares that may be acquired upon exercise of vested options.
(5)	Represents shares owned by Michael Gaynor Family Trust. Mr. Gaynor is trustee of Michael Gaynor Family Trust and has voting and depository power over these shares.
(6)	Includes 3,250,000 shares that may be acquired upon exercise of vested options.
(7)	ALMC-ASAP Holdings, Inc.’s shares are held by the Mattacchione Family Trust. Robert Mattacchione and Emily Mattacchione are co-trustees of the Mattacchione Family Trust and share voting and depository power over these shares.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

At August 31, 2017, the Company had outstanding advances totaling $1,812,613 due to related parties. These related parties are stockholders, officers and/or affiliates of the Company as well as owners, officers and/or shareholders of the companies that provided the advances to the Company. These amounts owed by the Company are non-interest bearing and payable upon demand.

At August 31, 2017, the Company had debentures totaling $5,114,327 due to the following related parties:

	●	$810,399 due to Peak Health LTC Inc., a company whose owner (Pierre Dalcourt) is a director and greater than 5% shareholder of the Company;

	●	$309,928 due to Michael Gaynor Physiotherapy PC, a company whose owner (Michael Gaynor) is an officer and director of the Company;

	●	$2,396,400 due to ICC Healthnet Canada, Inc., a company whose owner (Robert Mattacchione is a greater than 5% shareholder of the Company; and

	●	$1,597,600 due to Healthnet Assessment Inc., a company whose owner (Robert Mattacchione) is a greater than 5% shareholder of the Company.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Warren Averett served as our independent registered public accountants until May 31, 2017. In connection with the closing of the Share Exchange Agreement, on May 31, 2017, our board of directors terminated Warren Averett’s engagement and appointed AJ Robbins as the Company’s new independent registered accounting firm. The following table shows the fees that were billed for the audit and other services provided by AJ Robbins for the fiscal years ended August 31, 2017 and 2016.

	Fiscal Year Ended August 31,
	2017		2016
Audit Fees	$	105,250	$	—
Audit-Related Fees		37,000		—
Tax Fees		14,000		—
All Other Fees		0		—
Total	$	156,250	$	—

Audit Fees - This category includes the audit of our annual financial statements, review of financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided by the independent registered public accounting firm in connection with engagements for those fiscal years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.

Audit-Related Fees - This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees.” The services for the fees disclosed under this category include consultation regarding our correspondence with the SEC, other accounting consulting and other audit services.

Tax Fees - This category consists of professional services rendered by our independent registered public accounting firm for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.

All Other Fees - This category consists of fees for other miscellaneous items.

Board of Directors Pre-Approval Process, Policies and Procedures

All audit and permissible non-audit services provided by our independent registered public accounting firm must be pre-approved. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of service. The independent registered public accounting firm and management periodically report to the board of directors regarding the extent of services provided by the independent registered public accounting firm. Consistent with the board of directors’ policy, all audit and permissible non-audit services provided by our independent registered public accounting firm were pre-approved by our board of directors.

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

Exhibit Number		Description of Document

3.1		Amended and Restated Articles of Incorporation of the registrant (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Commission on June 5, 2017).

3.2		Bylaws dated February 15, 2008 (incorporated by reference to Exhibit 3.10 to the Company’s Annual Report on Form 10-K filed with the Commission on March 7, 2017).

10.1+		Future Services Agreement between Christopher David dated as of February 19, 2016 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on February 25, 2016).

10.2+		Employment Agreement, entered into on July 12, 2017 and effective July 1, 2017, between the registrant and Christopher David (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on July 18, 2017).

10.3+		2015 Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company’s registration statement on Form S-8 filed with the Commission on September 8, 2015).

10.4		Share Exchange Agreement dated April 25, 2017 by and between Turbine Truck Engines, Inc., Novo Healthnet Limited, ALMC-ASAP Holdings Inc., Michael Gaynor Family Trust, 1218814 Ontario Inc. and Michael Gaynor Physiotherapy Professional Corp. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on May 1, 2017).

10.5		Amendment No. 1 to Share Exchange Agreement dated as of May 3, 2017 by and between Turbine Truck Engines, Inc., Novo Healthnet Limited, ALMC-ASAP Holdings Inc., Michael Gaynor Family Trust, 1218814 Ontario Inc. and Michael Gaynor Physiotherapy Professional Corp. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on May 9, 2017).

10.6		Option to Purchase Common Stock, dated July 12, 2017 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Commission on July 18, 2017).

21.1*		Subsidiaries of the Company.

23.1*		Consent of AJ Robbins CPA, LLC, Independent Registered Public Accounting Firm.

31.1*		Rule 13a-14(a) Certification of Principal Executive Officer

31.2*		Rule 13a-14(a) Certification of Principal Financial Officer

32.1*		Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer

101.INS*		XBRL Instance Document

101.SCH*		XBRL Taxonomy Extension Schema Document

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase

101.DEF*		XBRL Taxonomy Extension Definition Linkbase

101.LAB*		XBRL Taxonomy Extension Labels Linkbase

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase

*	Filed herewith.
+	Management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NOVO INTEGRATED SCIENCES, INC.

Dated: December 8, 2017	By:	/s/ Christopher David
		Christopher David, President
		(principal executive officer)

Dated: December 8, 2017	By:	/s/ Klara Radulyne
		Klara Radulyne, Principal Financial Officer (principal financial officer and principal accounting officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Dated: December 8, 2017	By:	/s/ Christopher David
		Christopher David, President and Director (principal executive officer)

Dated: December 8, 2017	By:	/s/ Klara Radulyne
		Klara Radulyne, Principal Financial Officer (principal financial officer and principal accounting officer)

Dated: December 8, 2017	By:	/s/ Pierre Dalcourt
		Pierre Dalcourt, Chairman of the Board

Dated: December 8, 2017	By:	/s/ Michael Gaynor
		Michael Gaynor, Director

EX-21.1 2 ex21-1.htm

Exhibit 21.1

SUBSIDIARIES

The following is a list of the direct and indirect subsidiaries of Novo Integrated Sciences, Inc. as of August 31, 2017.

Company		Jurisdiction of Incorporation or Organization
Novo Healthnet Limited		Ontario, Canada
Novo Peak Health Inc.		Ontario, Canada
Novo Healthnet Rehab Limited		Ontario, Canada
Novo Healthnet Kemptville Centre, Inc. (1)		Ontario, Canada
Novo Assessments Inc.		Ontario, Canada

(1)	Novo Healthnet Limited owns an 80% interest in Novo Healthnet Kemptville Centre, Inc.

EX-23.1 3 ex23-1.htm

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

I hereby consent to the incorporation by reference in the Registration Statements on Form S-8 of Novo Integrated Sciences, Inc. of my report dated December 6, 2017, relating to the financial statements, which appears in this Form 10-K.

AJ Robbins CPA LLC
Denver, Colorado
December 6, 2017

EX-31.1 4 ex31-1.htm

Exhibit 31.1

CERTIFICATIONS

I, Christopher David, certify that:

1. I have reviewed this annual report on Form 10-K for the fiscal year ended August 31, 2017 of Novo Integrated Sciences, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 8, 2017

/s/ Christopher David
Christopher David
President (principal executive officer)

EX-31.2 5 ex31-2.htm

Exhibit 31.2

CERTIFICATIONS

I, Klara Radulyne, certify that:

1. I have reviewed this annual report on Form 10-K for the fiscal year ended August 31, 2017 of Novo Integrated Sciences, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 8, 2017

/s/ Klara Radulyne
Klara Radulyne
Principal Financial Officer
(principal financial officer)

EX-32.1 6 ex32-1.htm

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Novo Integrated Sciences, Inc. (the “Company”) for the fiscal year ended August 31, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Christopher David, President of the Company, and I, Klara Radulyne, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: December 8, 2017	/s/ Christopher David
	Christopher David, President (principal executive officer)

	/s/ Klara Radulyne
	Klara Radulyne, Principal Financial Officer (principal financial officer)

This certification accompanies this Annual Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

GRAPHIC 7 image_001.jpg begin 644 image_001.jpg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nvos-20170831.xml XBRL INSTANCE FILE 0001138978 2016-09-01 2017-08-31 0001138978 2017-12-06 0001138978 2017-08-31 0001138978 2016-08-31 0001138978 us-gaap:CommonStockMember 2016-09-01 2017-08-31 0001138978 us-gaap:CommonStockMember 2016-08-31 0001138978 us-gaap:CommonStockMember 2017-08-31 0001138978 us-gaap:AdditionalPaidInCapitalMember 2016-09-01 2017-08-31 0001138978 us-gaap:AdditionalPaidInCapitalMember 2016-08-31 0001138978 us-gaap:AdditionalPaidInCapitalMember 2017-08-31 0001138978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-09-01 2017-08-31 0001138978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-08-31 0001138978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-08-31 0001138978 us-gaap:RetainedEarningsMember 2016-09-01 2017-08-31 0001138978 us-gaap:RetainedEarningsMember 2016-08-31 0001138978 us-gaap:RetainedEarningsMember 2017-08-31 0001138978 NVOS:TotalNovoStockholdersDeficitMember 2016-09-01 2017-08-31 0001138978 us-gaap:NoncontrollingInterestMember 2016-09-01 2017-08-31 0001138978 us-gaap:NoncontrollingInterestMember 2016-08-31 0001138978 us-gaap:NoncontrollingInterestMember 2017-08-31 0001138978 2015-08-31 0001138978 NVOS:TotalNovoStockholdersDeficitMember 2016-08-31 0001138978 NVOS:TotalNovoStockholdersDeficitMember 2017-08-31 0001138978 NVOS:TurbineTruckEnginesIncMember 2016-09-01 2017-08-31 0001138978 NVOS:TurbineTruckEnginesIncOneMember 2016-09-01 2017-08-31 0001138978 NVOS:ShareExchangeAgreementMember NVOS:NHLMember 2017-04-23 2017-04-25 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2017-08-31 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2016-08-31 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2017-08-31 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2016-08-31 0001138978 NVOS:NovoHealthnetKemptvilleCentreIncMember 2017-08-31 0001138978 2015-09-01 2016-08-31 0001138978 us-gaap:LeaseholdImprovementsMember 2016-09-01 2017-08-31 0001138978 NVOS:ClinicalEquipmentMember 2016-09-01 2017-08-31 0001138978 us-gaap:ComputerEquipmentMember 2016-09-01 2017-08-31 0001138978 us-gaap:OfficeEquipmentMember 2016-09-01 2017-08-31 0001138978 us-gaap:FurnitureAndFixturesMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2016-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationOneMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationOneMember 2016-08-31 0001138978 NVOS:AdvanceToCorporationTwoMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationTwoMember 2016-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2015-09-01 2016-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2015-09-01 2016-08-31 0001138978 us-gaap:LeaseholdImprovementsMember 2017-08-31 0001138978 NVOS:ClinicalEquipmentMember 2017-08-31 0001138978 us-gaap:ComputerEquipmentMember 2017-08-31 0001138978 us-gaap:OfficeEquipmentMember 2017-08-31 0001138978 us-gaap:FurnitureAndFixturesMember 2017-08-31 0001138978 us-gaap:LeaseholdImprovementsMember 2016-08-31 0001138978 NVOS:ClinicalEquipmentMember 2016-08-31 0001138978 us-gaap:ComputerEquipmentMember 2016-08-31 0001138978 us-gaap:OfficeEquipmentMember 2016-08-31 0001138978 us-gaap:FurnitureAndFixturesMember 2016-08-31 0001138978 NVOS:NotePayableOneMember 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2017-08-31 0001138978 NVOS:NotePayableFourMember 2017-08-31 0001138978 NVOS:NotePayableOneMember 2016-08-31 0001138978 NVOS:NotePayableTwoMember 2016-08-31 0001138978 NVOS:NotePayableThreeMember 2016-08-31 0001138978 NVOS:NotePayableFourMember 2016-08-31 0001138978 NVOS:NotePayableOneMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableFourMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeOneMember 2017-08-31 0001138978 NVOS:ExercisePriceRangeTwoMember 2017-08-31 0001138978 NVOS:ExercisePriceRangeThreeMember 2017-08-31 0001138978 NVOS:ExercisePriceRangeFourMember 2017-08-31 0001138978 NVOS:ExercisePriceRangeFiveMember 2017-08-31 0001138978 NVOS:CADMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableOneMember 2015-09-01 2016-08-31 0001138978 NVOS:NotePayableTwoMember 2015-09-01 2016-08-31 0001138978 NVOS:NotePayableThreeMember 2015-09-01 2016-08-31 0001138978 NVOS:NotePayableFourMember 2015-09-01 2016-08-31 0001138978 us-gaap:CommonStockMember 2015-09-01 2016-08-31 0001138978 us-gaap:CommonStockMember 2015-08-31 0001138978 us-gaap:AdditionalPaidInCapitalMember 2015-09-01 2016-08-31 0001138978 us-gaap:AdditionalPaidInCapitalMember 2015-08-31 0001138978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-09-01 2016-08-31 0001138978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-08-31 0001138978 us-gaap:RetainedEarningsMember 2015-09-01 2016-08-31 0001138978 us-gaap:RetainedEarningsMember 2015-08-31 0001138978 NVOS:TotalNovoStockholdersDeficitMember 2015-09-01 2016-08-31 0001138978 NVOS:TotalNovoStockholdersDeficitMember 2015-08-31 0001138978 us-gaap:NoncontrollingInterestMember 2015-09-01 2016-08-31 0001138978 us-gaap:NoncontrollingInterestMember 2015-08-31 0001138978 2017-02-28 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2016-08-31 0001138978 NVOS:FiveDebenturesMember 2013-09-30 0001138978 NVOS:FiveDebenturesMember NVOS:CADMember 2017-08-31 0001138978 NVOS:DecemberTwoTwoThousandAndSeventeenMember 2016-09-01 2017-08-31 0001138978 NVOS:DecemberFiveTwoThousandAndSeventeenMember us-gaap:MaximumMember 2017-08-31 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember us-gaap:MaximumMember 2015-09-07 2015-09-08 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeSixMember 2017-08-31 0001138978 NVOS:UnitedStatesMember 2017-08-31 0001138978 NVOS:CanadaMember 2017-08-31 0001138978 us-gaap:SubsequentEventMember 2017-09-17 2017-09-18 0001138978 us-gaap:SubsequentEventMember 2017-11-29 2017-12-01 0001138978 us-gaap:SubsequentEventMember NVOS:FiveDebenturesMember 2017-12-02 0001138978 us-gaap:SubsequentEventMember NVOS:FiveDebenturesMember NVOS:CADMember 2017-12-02 0001138978 us-gaap:SubsequentEventMember NVOS:MarchEighteenTwoThousandAndEighteenMember 2016-09-01 2017-08-31 0001138978 us-gaap:SubsequentEventMember 2017-11-29 2017-12-02 0001138978 us-gaap:SubsequentEventMember 2017-12-05 0001138978 us-gaap:SubsequentEventMember 2017-12-04 2017-12-05 0001138978 NVOS:UnitedStatesMember 2016-09-01 2017-08-31 0001138978 NVOS:UnitedStatesMember 2015-09-01 2016-08-31 0001138978 NVOS:CanadaMember 2016-09-01 2017-08-31 0001138978 NVOS:CanadaMember 2015-09-01 2016-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD Novo Integrated Sciences, Inc. 0001138978 10-K 2017-08-31 false --08-31 Smaller Reporting Company FY 202221364

1896572

110315

68079

1128898

785780

372024

735330

39940

38099

299550

381000

32534

30481

285750

784833

252536

156221

3650030

2572479

302951

318718

5514390

2891197

1703342

2035328

341657

235420

403119

832766

1812613

1838592

13171

147517

4273902

9968337

414351

11580

9802580

9979917

201837

3381643

1240844

1277449

-9091977

-8353593

5514390

2891197

7963045

7178246

4985715

4670615

2977330

2507631

59026

25610

3090374

2385677

-113044

121954

-520518

-468132

-633562

-346178

-111702

-6880

-5649

-738384

-340529

-781869

-400893

-0.00

0.00

177675415

167797406

0.001

1000000

0.001

499000000

201837254

167797406

201837254

167797406

201837254

167797406

11288541

-252428

67776

72586

-412877

-152134

89937

-233300

310790

338877

-810687

101388

-749530

-462304

-85063

466291

3386560

3107539

402207

238935

945

1786257

42236

289316

-412216

84161

-9321

38238

54982

407322

131454

64084

The following table details the exchange rates used for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Period end: CAD to USD exchange rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7988</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7620</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Average period: CAD to USD exchange rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7573</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7543</td> <td style="line-height: 107%"> </td></tr> </table> Delaware State of Nevada 2000-11-27 2008-02-20

0.80

167797406

384110

0.7988

0.7620

0.7573

0.7543

7860000

P5Y

P3Y

P5Y

0.08

0.75

2016-09-30

2016-05-29

2017-10-31

2019-03-21

2019-04-08

2016-05-29

2017-10-31

2019-03-21

2019-04-08

2016-09-30

571056

506274

329985

177514

21020

24319

18218

310111

147429

8575

22780

17379

268105

187556

427522

159097

7134

399400

20988

91439

47636

20022

3567

608

3567

608

13171

414351

427522

7860000

6610000

1250000

120000

6860000

0.266

0.24

0.42

0.40

0.258

P3Y6M10D

660000

7860000

5500000

1000000

100000

1000000

250000

10000

0.16

0.32

0.50

0.62

0.80

2.00

6860000

5500000

100000

1000000

250000

10000

0.16

0.32

0.50

0.62

0.80

2.00

0.015

P2Y6M

3.23

0.00

22751307

0.58

0.42

252428

381585

2023

796745

763339

0.85

4878714

5114327

6402512

5114327

6402512

-20537

-12668

-4288190

-7088720

201837

3381643

1277449

1240844

-8353593

-9091977

-12668

-20537

-6687717

-7076052

-4267653

1332164

-8012884

-6680628

-7089

-4267653

-7076052

3031348

2360067

34139

55208

554657

523340

-745264

-738384

-6880

-346178

-340709

-5469

-36605

-54715

-37594

-36605

-989

-54825

-54715

-110

6904

190457

-183553

6904

3386560

11288

3375272

3386560

12249

399400

500000

507636

508161

0.08

0.12

2016-11-15

2018-05-23

0.12

0.072

0.00

0.06

0.12

0.072

0.00

0.06

P3Y4M2D

252428

NVOS 2017

60000

175611

135009

49294

100581

135009

-276582

-135009

-150265

-100581

-135009

1856218

1391467

No No Yes 3903769

5114327

399400

-62504 -62504 -62504 62504

1101639

186618

177271

The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

5000000

4987500

464751

132876

1856218

1391467

738000

3887000

111702

1856218

1391467

377830

292778

187985

169376

108793

54602

1191664

233155

2019-09-30 2019-09-30

-699551

-346178

-375662

-257900

-346178

111702

100971

0.400

0.390

-0.400

-0.390

0.000 0.433

0.269

0.000

0.131

0.390

0.176

0.000

0.433

0.000

1162009

378098

Note 1 - Organization and Basis of Presentation   Organization and Line of Business   Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.   We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.   On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).   On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.   The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.   On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31, but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.   Basis of Presentation   The accompanying consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).   Foreign Currency Translation   The accounts of the Company are maintained in CAD. The accounts of the Company are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Period end: CAD to USD exchange rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7988</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7620</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Average period: CAD to USD exchange rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7573</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7543</td> <td style="line-height: 107%"> </td></tr> </table>

Note 2 – Summary of Significant Accounting Policies   Use of Estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.   Principles of Consolidation   The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.   Noncontrolling Interest   The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.   The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).   Cash Equivalents   For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.   Accounts Receivable   Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of August 31, 2017 and 2016, the allowance for uncollectible accounts receivable was $507,636 and $508,161 respectively.   Property and Equipment   Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Leasehold improvements</td> <td style="width: 40%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table>   Long-Lived Assets   The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the discounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at August 31, 2017 and 2016, the Company believes there was no impairment of its long-lived assets.   Goodwill   Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $399,400 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.   Acquisition Deposits   The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,162,009.   Fair Value of Financial Instruments   For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.   FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%"> </td> <td style="width: 24px; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement. </td></tr> </table>   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.   As of August 31, 2017 and 2016, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.   Revenue Recognition   Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.   Income Taxes   The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.   Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.   Basic and Diluted Earnings Per Share   Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,860,000 options/warrants outstanding as of August 31, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.   Foreign Currency Transactions and Comprehensive Income   U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian dollar. Translation gains of $1,240,844 and $1,277,449 for the years ended August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.   Statement of Cash Flows   Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.   Recent Accounting Pronouncements   In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.   In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.   In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.   In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.   Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Note 3 – Related Party Transactions   Due to related parties   Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.

Note 4 – Other Receivables   Other receivables at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; was due on November 15, 2016.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">39,940</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">38,099</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">299,550</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">285,750</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">381,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">32,534</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">30,481</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total other receivables</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">372,024</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">735,330</td> <td style="line-height: 107%"> </td></tr> </table>

Note 5 – Property and Equipment   Property and equipment at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Leasehold Improvements</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">329,985</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">310,111</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">177,514</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">147,429</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,020</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,575</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">24,319</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">22,780</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">18,218</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">17,379</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">571,056</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">506,274</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(268,105</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(187,556</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">302,951</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">318,718</td> <td style="line-height: 107%"> </td></tr> </table>   Depreciation expense for the years ended August 31, 2017 and 2016 was $67,776 and $72,586, respectively.

Note 6 – Notes Payable   Notes payable at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2017</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2016</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Notes payable to five individuals; accrues interest at 12% per annum; secured by assets of the Company; due May 29, 2016. These notes were fully repaid.</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">91,439</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017.</td> <td> </td> <td> </td> <td style="text-align: right">7,134</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">47,636</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.</td> <td> </td> <td> </td> <td style="text-align: right">399,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable to financial institution; accrues interest at 6% per annum; monthly principal and interest payment of $608; unsecured; due April 8, 2019.</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">20,988</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">20,022</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right">427,522</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">159,097</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Current portion</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,171</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(147,517</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Long-term portion</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">414,351</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">11,580</td> <td> </td></tr> </table>   Aggregate future maturities of notes payable as of August 31, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Years ending August 31:</td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; text-align: right">2018</td> <td style="width: 3%"> </td> <td style="width: 1%">$</td> <td style="width: 27%; text-align: right">13,171</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">2019</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">414,351</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">427,522</td> <td> </td></tr> </table>

Note 7 – Debentures, related parties   On September 30, 2013, the Company issued five debentures totaling $5,114,327 (CAD$6,402,512) at August 31, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019. On December 5, 2017, the debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value plus any interest or fees owed to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

Note 8 – Stockholders’ Deficit   Convertible preferred stock   The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. As of August 31, 2017 and 2016 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.   Common stock   The Company has authorized 499,000,000 shares of $0.001 par value common stock. As of August 31, 2017 and 2016 there were 201,837,254 and 167,797,406 common shares issued and outstanding, respectively.   During the year ended August 31, 2017 the Company issued:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%"> </td> <td style="width: 24px; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">22,751,307 shares of common stock in connection with the reverse merger transaction; and</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">11,288,541 shares of common stock for cash proceeds of $3,386,560.</td></tr> </table>   Stock Options and Warrants   On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.   The following is a summary of stock option/warrant activity:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Remaining</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Aggregate</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Contractual</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Intrinsic</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Outstanding</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Life</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding, August 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; line-height: 107%">Transfer from reverse merger transactions</td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%">6,610,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 10%; text-align: right; line-height: 107%">0.24</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.42</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Forfeited</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Outstanding, August 31, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">7,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.266</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">3.53</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">660,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable, August 31, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.258</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">3.34</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">660,000</td> <td style="line-height: 107%"> </td></tr> </table>   The exercise price for options/warrants outstanding at August 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Outstanding</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Exercisable</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%">Number of</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Number of</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 25%; text-align: right; line-height: 107%">5,500,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 21%; text-align: right; line-height: 107%">0.16</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 22%; text-align: right; line-height: 107%">5,500,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 21%; text-align: right; line-height: 107%">0.16</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.32</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.32</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.50</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.50</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.62</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.62</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.80</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.80</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">10,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2.00</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">10,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2.00</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">7,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>   For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.   The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $252,428 during the year ended August 31, 2017. At August 31, 2017, the unamortized stock option expense was $381,585.   The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="width: 50%; line-height: 107%">Risk-free interest rate</td> <td nowrap="nowrap" style="width: 1%; line-height: 107%"> </td> <td nowrap="nowrap" style="width: 49%; text-align: center; line-height: 107%">1.5%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="line-height: 107%">Expected life of the options</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">2.5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="line-height: 107%">Expected volatility</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">323%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="line-height: 107%">Expected dividend yield</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">0%</td></tr> </table>

Note 9 – Income Taxes   The Company’s Canadian subsidiaries are subject to the income tax laws of the Province of Ontario and the country of Canada.   Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A full valuation allowance is established against all net deferred tax assets as of August 31, 2017 and 2016 based on estimates of recoverability. While the Company has optimistic plans for its business strategy, it determined that such a valuation allowance was necessary given the current and expected near term losses and the uncertainty with respect to its ability to generate sufficient profits from its business model.   Income tax expense for the years ended August 31, 2017 and 2016 is a follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Current taxes:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Federal</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">State</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; line-height: 107%">Foreign</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">111,702</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Deferred taxes:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Federal</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">State</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Foreign</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total income tax expense</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>   A reconciliation of the differences between the effective and statutory income tax rates are as follows:   Year Ended August 31, 2017   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Canada</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">United States</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Combined statutory tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">40.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Pretax loss</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(257,900</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(375,662</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(699,551</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected income tax expense (benefit)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(100,581</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(150,265</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-40.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(276,582</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Income tax from subsidiaries not part of consolidated return</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">43.3</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Stock based compensation</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,971</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">26.9</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,971</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">100,581</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">49,294</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">13.1</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">175,611</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">43.3</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">17.6</td> <td style="line-height: 107%">%</td></tr> </table>   Year Ended August 31, 2016   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Canada</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">United States</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; line-height: 107%">Combined statutory tax rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="width: 7%; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">39.0</td> <td style="width: 1%; line-height: 107%">%</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="width: 7%; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">40.0</td> <td style="width: 1%; line-height: 107%">%</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Pretax loss</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(346,178</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(346,178</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected income tax expense (benefit)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(135,009</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(135,009</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">135,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">135,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td></tr> </table>   At August 31, 2017 and 2016, the significant components of the deferred tax assets are summarized below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; line-height: 107%">Net operating loss carryforwards</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">1,856,218</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">1,391,467</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt; line-height: 107%">Total deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,856,218</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,391,467</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Less: valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,856,218</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,391,467</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>   The valuation allowance for the years ended August 31, 2017 and 2016 increased by $464,751 and $132,876, respectively, as a result of the Company generating additional net operating losses and additional net operating losses resulting from the merger transaction.   The Company has recorded as of August 31, 2017 a valuation allowance of $1,856,218, as it believes that it is more likely than not that the deferred tax assets will not be realized in future years. Management has based its assessment on the Company’s lack of profitable operating history.   The Company conducts an analysis of its tax positions and has concluded that it has no uncertain tax positions as of August 31, 2017 and 2016.   The Company has net operating loss carry-forwards of approximately $738,000 and $3,887,000 in the United States and Canada, respectively. The use of the net operating losses in the United States may be significantly limited due to Internal Revenue Code section 382. The 2017, 2016 and 2015 tax years are still subject to audit.

Note 10 – Acquisition of Assets   During the year ended August 31, 2017, the Company acquired certain assets in exchange for a note payable of $399,400 (CAD$500,000) at April 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

Note 11 – Commitments and Contingencies   Litigation   The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of August 31, 2017, results of operations, cash flows or liquidity of the Company.   Leases   The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $796,745 and $763,339 for the years ended August 31, 2017 and 2016, respectively.   Future minimum annual payments under operating lease agreements for fiscal years ending August 31 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Years ending August 31:</td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%; text-align: right; line-height: 107%">2018</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">377,830</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">2019</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">292,778</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">2020</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">187,985</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">2021</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">169,376</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">2022</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">108,793</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">Thereafter</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">54,902</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,191,664</td> <td style="line-height: 107%"> </td></tr> </table>

Note 12 – Subsequent Events   On September 18, 2017, an independent consultant was granted 120,000 stock options of the Company’s common stock with an exercise price of $0.40. Of these, 60,000 options vest on September 18, 2017 and 60,000 options vest on March 18, 2018.   On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.   On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $5,114,327 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see financial note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.   On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

Use of Estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Principles of Consolidation   The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

Noncontrolling Interest   The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.   The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents   For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

Accounts Receivable   Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of August 31, 2017 and 2016, the allowance for uncollectible accounts receivable was $507,636 and $508,161 respectively.

Property and Equipment   Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Leasehold improvements</td> <td style="width: 40%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table>

Long-Lived Assets   The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the discounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at August 31, 2017 and 2016, the Company believes there was no impairment of its long-lived assets.

Goodwill   Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $399,400 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.

Acquisition Deposits   The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,162,009.

Fair Value of Financial Instruments   For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.   FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%"> </td> <td style="width: 24px; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement. </td></tr> </table>   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.   As of August 31, 2017 and 2016, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition   Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Income Taxes   The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.   Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

Basic and Diluted Earnings Per Share   Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,860,000 options/warrants outstanding as of August 31, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

Foreign Currency Transactions and Comprehensive Income   U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian dollar. Translation gains of $1,240,844 and $1,277,449 for the years ended August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows   Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

Recent Accounting Pronouncements   In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.   In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.   In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.   In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.   Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Leasehold improvements</td> <td style="width: 40%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table> Other receivables at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; was due on November 15, 2016.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">39,940</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">38,099</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">299,550</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">285,750</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">381,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">32,534</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">30,481</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total other receivables</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">372,024</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">735,330</td> <td style="line-height: 107%"> </td></tr> </table>

Property and equipment at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Leasehold Improvements</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">329,985</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">310,111</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">177,514</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">147,429</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,020</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,575</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">24,319</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">22,780</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">18,218</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">17,379</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">571,056</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">506,274</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(268,105</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(187,556</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">302,951</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">318,718</td> <td style="line-height: 107%"> </td></tr> </table>

Notes payable at August 31, 2017 and 2016 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2017</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2016</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Notes payable to five individuals; accrues interest at 12% per annum; secured by assets of the Company; due May 29, 2016. These notes were fully repaid.</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">91,439</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017.</td> <td> </td> <td> </td> <td style="text-align: right">7,134</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">47,636</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.</td> <td> </td> <td> </td> <td style="text-align: right">399,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Notes payable to financial institution; accrues interest at 6% per annum; monthly principal and interest payment of $608; unsecured; due April 8, 2019.</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">20,988</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">20,022</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right">427,522</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">159,097</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Current portion</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,171</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(147,517</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Long-term portion</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">414,351</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">11,580</td> <td> </td></tr> </table>

Aggregate future maturities of notes payable as of August 31, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Years ending August 31:</td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; text-align: right">2018</td> <td style="width: 3%"> </td> <td style="width: 1%">$</td> <td style="width: 27%; text-align: right">13,171</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">2019</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">414,351</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">427,522</td> <td> </td></tr> </table>

The following is a summary of stock option/warrant activity:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Remaining</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Aggregate</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Contractual</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Intrinsic</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Outstanding</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Life</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding, August 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; line-height: 107%">Transfer from reverse merger transactions</td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%">6,610,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 10%; text-align: right; line-height: 107%">0.24</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 2%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 10%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.42</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Forfeited</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Outstanding, August 31, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">7,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.266</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">3.53</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">660,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable, August 31, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.258</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">3.34</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">660,000</td> <td style="line-height: 107%"> </td></tr> </table>

The exercise price for options/warrants outstanding at August 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Outstanding</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Exercisable</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%">Number of</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Number of</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Options/</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 25%; text-align: right; line-height: 107%">5,500,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 21%; text-align: right; line-height: 107%">0.16</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 22%; text-align: right; line-height: 107%">5,500,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 21%; text-align: right; line-height: 107%">0.16</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.32</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.32</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.50</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.50</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.62</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,000,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.62</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.80</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">250,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.80</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">10,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2.00</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">10,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2.00</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">7,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,860,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="width: 50%; line-height: 107%">Risk-free interest rate</td> <td nowrap="nowrap" style="width: 1%; line-height: 107%"> </td> <td nowrap="nowrap" style="width: 49%; text-align: center; line-height: 107%">1.5%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="line-height: 107%">Expected life of the options</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">2.5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="line-height: 107%">Expected volatility</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">323%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="line-height: 107%">Expected dividend yield</td> <td nowrap="nowrap" style="line-height: 107%"> </td> <td nowrap="nowrap" style="text-align: center; line-height: 107%">0%</td></tr> </table>

Income tax expense for the years ended August 31, 2017 and 2016 is a follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Current taxes:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Federal</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">State</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; line-height: 107%">Foreign</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">111,702</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Deferred taxes:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Federal</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">State</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Foreign</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total income tax expense</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

A reconciliation of the differences between the effective and statutory income tax rates are as follows:   Year Ended August 31, 2017   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Canada</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">United States</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 7%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Combined statutory tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">40.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Pretax loss</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(257,900</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(375,662</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(699,551</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected income tax expense (benefit)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(100,581</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(150,265</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-40.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(276,582</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Income tax from subsidiaries not part of consolidated return</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">43.3</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Stock based compensation</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,971</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">26.9</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">100,971</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">100,581</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">49,294</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">13.1</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">175,611</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">43.3</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">111,702</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">17.6</td> <td style="line-height: 107%">%</td></tr> </table>   Year Ended August 31, 2016   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Canada</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">United States</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; line-height: 107%">Combined statutory tax rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="width: 7%; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">39.0</td> <td style="width: 1%; line-height: 107%">%</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="width: 7%; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">40.0</td> <td style="width: 1%; line-height: 107%">%</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 7%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Pretax loss</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(346,178</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(346,178</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected income tax expense (benefit)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(135,009</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(135,009</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">135,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">39.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">135,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0</td> <td style="line-height: 107%">%</td></tr> </table>

At August 31, 2017 and 2016, the significant components of the deferred tax assets are summarized below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; line-height: 107%">Net operating loss carryforwards</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">1,856,218</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">1,391,467</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 20pt; line-height: 107%">Total deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,856,218</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,391,467</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Less: valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,856,218</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,391,467</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total deferred income tax asset</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

Future minimum annual payments under operating lease agreements for fiscal years ending August 31 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Years ending August 31:</td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%; text-align: right; line-height: 107%">2018</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">377,830</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">2019</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">292,778</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">2020</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">187,985</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">2021</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">169,376</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">2022</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">108,793</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right; line-height: 107%">Thereafter</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">54,902</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,191,664</td> <td style="line-height: 107%"> </td></tr> </table>

EX-101.SCH 9 nvos-20170831.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Other Receivables link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Debentures, Related Parties link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Acquisition of Assets link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Organization and Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stockholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Organization and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Debentures, Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stockholders’ Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Income Taxes - Schedule of Effective and Statutory Income Tax Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Income Taxes - Schedule of the Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Acquisition of Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Annual Payments Under Operating Lease (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 nvos-20170831_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 nvos-20170831_def.xml XBRL DEFINITION FILE EX-101.LAB 12 nvos-20170831_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Other Comprehensive Income [Member] Accumulated Deficit [Member] Total Novo Stockholders' Deficit [Member] Noncontrolling Interest [Member] Total Novo Stockholders, Deficit [Member] Legal Entity [Axis] Turbine Truck Engines, Inc [Member] Turbine Truck Engines, Inc One [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Share Exchange Agreement [Member] NHL [Member] Report Date [Axis] Period End [Member] Currency [Axis] CAD [Member] Average Period [Member] Novo Healthnet Kemptville Centre, Inc [Member] Property, Plant and Equipment, Type [Axis] Leasehold Improvements [Member] Clinical Equipment [Member] Computer Equipment [Member] Office Equipment [Member] Furniture and Fixtures [Member] Receivable Type [Axis] Notes Receivable Dated November 15, 2014 [Member] Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member] Advance to Corporation One [Member] Advance to Corporation Two [Member] Debt Instrument [Axis] Note Payable One [Member] Note Payable Two [Member] Note Payable Three [Member] Note Payable Four [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Exercise Price Range Five [Member] Five Debentures [Member] December 2, 2017 [Member] December 5, 2017 [Member] Range [Axis] Maximum [Member] Plan Name [Axis] 2015 Incentive Compensation Plan [Member] Exercise Price Range Six [Member] Geographical [Axis] United States [Member] Canada [Member] Subsequent Event Type [Axis] Subsequent Event [Member] March 18, 2018 [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Other receivables Due from related parties Prepaid expenses and other current assets Total current assets Property and equipment, net Acquisition deposits Goodwill TOTAL ASSETS LIABILITIES AND DEFICIT Current Liabilities: Accounts payable Accrued expenses Accrued interest (principally to related parties) Due to related parties Notes payable, current portion Debentures, related parties Total current liabilities Debentures, related parties Notes payable, net of current portion TOTAL LIABILITIES Commitments and contingencies (Note 10) DEFICIT Novo Integrated Sciences, Inc. Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2017 and 2016 Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 167,797,406 shares issued and outstanding at August 31, 2017 and 2016 Additional paid-in capital Other comprehensive income Accumulated deficit Total Novo Integrated Sciences, Inc. stockholders' deficit Noncontrolling interest Total deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Convertible preferred stock, par value Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross profit Operating expenses: Selling expenses General and administrative expenses Total operating expenses Income (loss) from operations Non operating income (expense) Interest income Interest expense Total other income (expense) Loss before income taxes Income tax expense Net loss Net loss attributed to noncontrolling interest Net loss attributed to Novo Integrated Sciences, Inc. Comprehensive loss: Net loss Foreign currency translation gain (loss) Comprehensive loss Weighted average common shares outstanding - basic and diluted Net loss per common share - basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Foreign currency translation loss/gain Common stock issued in connection with reverse merger transaction Common stock issued in connection with reverse merger transaction, shares Common stock issued for cash Common stock issued for cash, shares Offering costs Fair value of vested stock options Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation Fair value of vested stock options Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and other current assets Accounts payable Accrued expenses Accrued interest Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of furniture and equipment Amounts loaned for other receivables Repayments of other receivables Deposit paid for acquisition Cash acquired in reverse merger transaction Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Advances (repayments) to related parties Proceeds from the sale of common stock Offering cost paid Payments on notes payable Net cash provided by financing activities Effect of exchange rate changes on cash and equivalents NET INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD CASH PAID FOR: Interest Income taxes SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES: Note payable issued for purchase of assets Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Related Party Transactions [Abstract] Related Party Transactions EX-101.PRE 13 nvos-20170831_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Aug. 31, 2017	Dec. 06, 2017	Feb. 28, 2017
Document And Entity Information
Entity Registrant Name	Novo Integrated Sciences, Inc.
Entity Central Index Key	0001138978
Document Type	10-K
Document Period End Date	Aug. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 3,903,769
Entity Common Stock, Shares Outstanding		202,221,364
Trading Symbol	NVOS
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2017

XML 15 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Current Assets:
Cash and cash equivalents	$ 1,896,572	$ 110,315
Accounts receivable, net	1,128,898	785,780
Other receivables	372,024	735,330
Due from related parties		784,833
Prepaid expenses and other current assets	252,536	156,221
Total current assets	3,650,030	2,572,479
Property and equipment, net	302,951	318,718
Acquisition deposits	1,162,009
Goodwill	399,400
TOTAL ASSETS	5,514,390	2,891,197
Current Liabilities:
Accounts payable	1,703,342	2,035,328
Accrued expenses	341,657	235,420
Accrued interest (principally to related parties)	403,119	832,766
Due to related parties	1,812,613	1,838,592
Notes payable, current portion	13,171	147,517
Debentures, related parties		4,878,714
Total current liabilities	4,273,902	9,968,337
Debentures, related parties	5,114,327
Notes payable, net of current portion	414,351	11,580
TOTAL LIABILITIES	9,802,580	9,979,917
Commitments and contingencies (Note 10)
Novo Integrated Sciences, Inc.
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2017 and 2016
Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 167,797,406 shares issued and outstanding at August 31, 2017 and 2016	201,837	92
Additional paid-in capital	3,381,643
Other comprehensive income	1,240,844	1,277,449
Accumulated deficit	(9,091,977)	(8,353,593)
Total Novo Integrated Sciences, Inc. stockholders' deficit	(4,267,653)	(7,076,052)
Noncontrolling interest	(20,537)	(12,668)
Total deficit	(4,288,190)	(7,088,720)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 5,514,390	$ 2,891,197

XML 16 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - $ / shares	Aug. 31, 2017	Aug. 31, 2016
Statement of Financial Position [Abstract]
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	1,000,000	1,000,000
Convertible preferred stock, shares issued	0	0
Convertible preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	499,000,000	499,000,000
Common stock, shares issued	201,837,254	167,797,406
Common stock, shares outstanding	201,837,254	167,797,406

XML 17 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Income Statement [Abstract]
Revenues	$ 7,963,045	$ 7,178,246
Cost of revenues	4,985,715	4,670,615
Gross profit	2,977,330	2,507,631
Operating expenses:
Selling expenses	59,026	25,610
General and administrative expenses	3,031,348	2,360,067
Total operating expenses	3,090,374	2,385,677
Income (loss) from operations	(113,044)	121,954
Non operating income (expense)
Interest income	34,139	55,208
Interest expense	(554,657)	(523,340)
Total other income (expense)	(520,518)	(468,132)
Loss before income taxes	(633,562)	(346,178)
Income tax expense	111,702
Net loss	(745,264)	(346,178)
Net loss attributed to noncontrolling interest	(6,880)	(5,649)
Net loss attributed to Novo Integrated Sciences, Inc.	(738,384)	(340,529)
Comprehensive loss:
Net loss	(745,264)	(346,178)
Foreign currency translation gain (loss)	(36,605)	(54,715)
Comprehensive loss	$ (781,869)	$ (400,893)
Weighted average common shares outstanding - basic and diluted	177,675,415	167,797,406
Net loss per common share - basic and diluted	$ (0.00)	$ 0.00

XML 18 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total Novo Stockholders' Deficit [Member]	Noncontrolling Interest [Member]	Total
Balance at Aug. 31, 2015	$ 92		$ 1,332,164	$ (8,012,884)	$ (6,680,628)	$ (7,089)	$ (6,687,717)
Balance, shares at Aug. 31, 2015	167,797,406
Foreign currency translation loss/gain			(54,715)		(54,715)	(110)	(54,825)
Net loss				(340,709)	(340,709)	(5,469)	(346,178)
Balance at Aug. 31, 2016	$ 92		1,277,449	(8,353,593)	(7,076,052)	(12,668)	(7,088,720)
Balance, shares at Aug. 31, 2016	167,797,406
Foreign currency translation loss/gain			(36,605)		(36,605)	(989)	(37,594)
Common stock issued in connection with reverse merger transaction	$ 190,457	(183,553)			6,904		$ 6,904
Common stock issued in connection with reverse merger transaction, shares	22,751,307						22,751,307
Common stock issued for cash	$ 11,288	3,375,272			3,386,560		$ 3,386,560
Common stock issued for cash, shares	11,288,541						11,288,541
Offering costs		(62,504)			(62,504)		$ (62,504)
Fair value of vested stock options		252,428			252,428		252,428
Net loss				(738,384)	(738,384)	(6,880)	(745,264)
Balance at Aug. 31, 2017	$ 201,837	$ 3,381,643	$ 1,240,844	$ (9,091,977)	$ (4,267,653)	$ (20,537)	$ (4,288,190)
Balance, shares at Aug. 31, 2017	201,837,254

XML 19 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (745,264)	$ (346,178)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	67,776	72,586
Fair value of vested stock options	252,428
Changes in operating assets and liabilities:
Accounts receivable	(289,316)	412,216
Prepaid expenses and other current assets	(84,161)	9,321
Accounts payable	(412,877)	(152,134)
Accrued expenses	89,937	(233,300)
Accrued interest	310,790	338,877
Net cash provided by (used in) operating activities	(810,687)	101,388
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and equipment	(38,238)	(54,982)
Amounts loaned for other receivables		(407,322)
Repayments of other receivables	378,098
Deposit paid for acquisition	(1,101,639)
Cash acquired in reverse merger transaction	12,249
Net cash used in investing activities	(749,530)	(462,304)
CASH FLOWS FROM FINANCING ACTIVITIES:
Advances (repayments) to related parties	(85,063)	466,291
Proceeds from the sale of common stock	3,386,560
Offering cost paid	(62,504)
Payments on notes payable	(131,454)	(64,084)
Net cash provided by financing activities	3,107,539	402,207
Effect of exchange rate changes on cash and equivalents	238,935	945
NET INCREASE IN CASH AND CASH EQUIVALENTS	1,786,257	42,236
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	110,315	68,079
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,896,572	110,315
Interest	186,618	177,271
Income taxes
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:
Note payable issued for purchase of assets	$ 399,400

XML 20 R7.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation

12 Months Ended

Aug. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

Organization and Line of Business

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

Basis of Presentation

Foreign Currency Translation

	August 31, 2017		August 31, 2016

Period end: CAD to USD exchange rate	$	0.7988	$	0.7620
Average period: CAD to USD exchange rate	$	0.7573	$	0.7543

XML 21 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

12 Months Ended

Aug. 31, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Use of Estimates

Principles of Consolidation

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

Accounts Receivable

Property and Equipment

Leasehold improvements	5 years
Clinical equipment	5 years
Computer equipment	3 years
Office equipment	5 years
Furniture and fixtures	5 years

Long-Lived Assets

Goodwill

Acquisition Deposits

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,162,009.

Fair Value of Financial Instruments

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement.

As of August 31, 2017 and 2016, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Income Taxes

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian dollar. Translation gains of $1,240,844 and $1,277,449 for the years ended August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows

Recent Accounting Pronouncements

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

XML 22 R9.htm IDEA: XBRL DOCUMENT

Related Party Transactions

12 Months Ended

Aug. 31, 2017

Related Party Transactions

Note 3 – Related Party Transactions

Due to related parties

Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.

XML 23 R10.htm IDEA: XBRL DOCUMENT

Other Receivables

12 Months Ended

Aug. 31, 2017

Receivables [Abstract]

Other Receivables

Note 4 – Other Receivables

Other receivables at August 31, 2017 and 2016 consisted of the following:

	2017		2016
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; was due on November 15, 2016.	$	39,940	$	38,099

Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.		299,550		285,750

Advance to corporation; non-interest bearing; unsecured; payable upon demand		-		381,000

Advance to corporation; non-interest bearing; unsecured; payable upon demand		32,534		30,481
Total other receivables	$	372,024	$	735,330

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 24 R11.htm IDEA: XBRL DOCUMENT

Property and Equipment

12 Months Ended

Aug. 31, 2017

Property, Plant and Equipment [Abstract]

Property and Equipment

Note 5 – Property and Equipment

Property and equipment at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Leasehold Improvements	$	329,985		$	310,111
Clinical equipment		177,514			147,429
Computer equipment		21,020			8,575
Office equipment		24,319			22,780
Furniture and fixtures		18,218			17,379
		571,056			506,274
Accumulated depreciation		(268,105	)		(187,556	)
Total	$	302,951		$	318,718

Depreciation expense for the years ended August 31, 2017 and 2016 was $67,776 and $72,586, respectively.

XML 25 R12.htm IDEA: XBRL DOCUMENT

Notes Payable

12 Months Ended

Aug. 31, 2017

Debt Disclosure [Abstract]

Notes Payable

Note 6 – Notes Payable

Notes payable at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Notes payable to five individuals; accrues interest at 12% per annum; secured by assets of the Company; due May 29, 2016. These notes were fully repaid.	$	-		$	91,439

Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017.		7,134			47,636

Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.		399,400			-

Notes payable to financial institution; accrues interest at 6% per annum; monthly principal and interest payment of $608; unsecured; due April 8, 2019.		20,988			20,022
		427,522			159,097
Current portion		(13,171	)		(147,517	)
Long-term portion	$	414,351		$	11,580

Aggregate future maturities of notes payable as of August 31, 2017 are as follows:

Years ending August 31:
2018	$	13,171
2019		414,351
	$	427,522

XML 26 R13.htm IDEA: XBRL DOCUMENT

Debentures, Related Parties

12 Months Ended

Aug. 31, 2017

Debt Disclosure [Abstract]

Debentures, Related Parties

Note 7 – Debentures, related parties

XML 27 R14.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit

12 Months Ended

Aug. 31, 2017

Equity [Abstract]

Stockholders' Deficit

Note 8 – Stockholders’ Deficit

Convertible preferred stock

Common stock

During the year ended August 31, 2017 the Company issued:

	●	22,751,307 shares of common stock in connection with the reverse merger transaction; and

	●	11,288,541 shares of common stock for cash proceeds of $3,386,560.

Stock Options and Warrants

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2016		-
Transfer from reverse merger transactions		6,610,000	$	0.24
Granted		1,250,000	$	0.42
Forfeited		-
Exercised		-
Outstanding, August 31, 2017		7,860,000	$	0.266		3.53	$	660,000
Exercisable, August 31, 2017		6,860,000	$	0.258		3.34	$	660,000

The exercise price for options/warrants outstanding at August 31, 2017:

Outstanding				Exercisable
Number of				Number of
Options/		Exercise		Options/		Exercise
Warrants		Price		Warrants		Price
	5,500,000	$	0.16		5,500,000	$	0.16
	1,000,000		0.32		-		0.32
	100,000		0.50		100,000		0.50
	1,000,000		0.62		1,000,000		0.62
	250,000		0.80		250,000		0.80
	10,000		2.00		10,000		2.00
	7,860,000				6,860,000

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate		1.5%
Expected life of the options		2.5 years
Expected volatility		323%
Expected dividend yield		0%

XML 28 R15.htm IDEA: XBRL DOCUMENT

Income Taxes

12 Months Ended

Aug. 31, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Note 9 – Income Taxes

The Company’s Canadian subsidiaries are subject to the income tax laws of the Province of Ontario and the country of Canada.

Income tax expense for the years ended August 31, 2017 and 2016 is a follows:

	2017		2016

Current taxes:
Federal	$	-	$	-
State		-		-
Foreign		111,702		-
		111,702		-
Deferred taxes:
Federal		-		-
State		-		-
Foreign		-		-
		-		-

Total income tax expense	$	111,702	$	-

A reconciliation of the differences between the effective and statutory income tax rates are as follows:

Year Ended August 31, 2017

	Canada					United States					Total

Combined statutory tax rate				39.0	%				40.0	%

Pretax loss	$	(257,900	)			$	(375,662	)			$	(699,551	)

Expected income tax expense (benefit)		(100,581	)	-39.0	%		(150,265	)	-40.0	%		(276,582	)
Income tax from subsidiaries not part of consolidated return		111,702		43.3	%		-		0.0	%		111,702
Stock based compensation		-		0.0	%		100,971		26.9	%		100,971
Change in valuation allowance		100,581		39.0	%		49,294		13.1	%		175,611
	$	111,702		43.3	%	$	-		0.0	%	$	111,702		17.6	%

Year Ended August 31, 2016

	Canada					United States				Total

Combined statutory tax rate				39.0	%			40.0	%

Pretax loss	$	(346,178	)			$	-			$	(346,178	)

Expected income tax expense (benefit)		(135,009	)	-39.0	%						(135,009	)
Change in valuation allowance		135,009		39.0	%						135,009
	$	-		0.0	%	$	-	0.0	%	$	-		0.0	%

At August 31, 2017 and 2016, the significant components of the deferred tax assets are summarized below:

	2017			2016
Deferred income tax asset
Net operating loss carryforwards	$	1,856,218		$	1,391,467
Total deferred income tax asset		1,856,218			1,391,467
Less: valuation allowance		(1,856,218	)		(1,391,467	)
Total deferred income tax asset	$	-		$	-

The Company conducts an analysis of its tax positions and has concluded that it has no uncertain tax positions as of August 31, 2017 and 2016.

XML 29 R16.htm IDEA: XBRL DOCUMENT

Acquisition of Assets

12 Months Ended

Aug. 31, 2017

Business Combinations [Abstract]

Acquisition of Assets

Note 10 – Acquisition of Assets

XML 30 R17.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

12 Months Ended

Aug. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 11 – Commitments and Contingencies

Litigation

Leases

Future minimum annual payments under operating lease agreements for fiscal years ending August 31 are as follows:

Years ending August 31:
2018	$	377,830
2019		292,778
2020		187,985
2021		169,376
2022		108,793
Thereafter		54,902
	$	1,191,664

XML 31 R18.htm IDEA: XBRL DOCUMENT

Subsequent Events

12 Months Ended

Aug. 31, 2017

Subsequent Events [Abstract]

Subsequent Events

Note 12 – Subsequent Events

XML 32 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Aug. 31, 2017

Accounting Policies [Abstract]

Use of Estimates

Principles of Consolidation

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

Accounts Receivable

Property and Equipment

Leasehold improvements	5 years
Clinical equipment	5 years
Computer equipment	3 years
Office equipment	5 years
Furniture and fixtures	5 years

Long-lived Assets

Long-Lived Assets

Goodwill

Acquisition Deposits

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,162,009.

Fair Value of Financial Instruments

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement.

As of August 31, 2017 and 2016, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Income Taxes

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian dollar. Translation gains of $1,240,844 and $1,277,449 for the years ended August 31, 2017 and 2016, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows

Recent Accounting Pronouncements

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. ASU 2016-09, which amends several aspects of accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. ASU 2014-15 requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods thereafter. Early adoption is permitted. The adoption of this ASU did not have an impact on the Company’s financial statements.

XML 33 R20.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Tables)

12 Months Ended

Aug. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Foreign Currency Translation, Exchange Rate Used

The following table details the exchange rates used for the respective periods:

	August 31, 2017		August 31, 2016

Period end: CAD to USD exchange rate	$	0.7988	$	0.7620
Average period: CAD to USD exchange rate	$	0.7573	$	0.7543

XML 34 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Aug. 31, 2017

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives of Assets

Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

Leasehold improvements	5 years
Clinical equipment	5 years
Computer equipment	3 years
Office equipment	5 years
Furniture and fixtures	5 years

XML 35 R22.htm IDEA: XBRL DOCUMENT

Other Receivables (Tables)

12 Months Ended

Aug. 31, 2017

Receivables [Abstract]

Schedule of Other Receivables

Other receivables at August 31, 2017 and 2016 consisted of the following:

	2017		2016
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; was due on November 15, 2016.	$	39,940	$	38,099

Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.		299,550		285,750

Advance to corporation; non-interest bearing; unsecured; payable upon demand		-		381,000

Advance to corporation; non-interest bearing; unsecured; payable upon demand		32,534		30,481
Total other receivables	$	372,024	$	735,330

XML 36 R23.htm IDEA: XBRL DOCUMENT

Property and Equipment (Tables)

12 Months Ended

Aug. 31, 2017

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Leasehold Improvements	$	329,985		$	310,111
Clinical equipment		177,514			147,429
Computer equipment		21,020			8,575
Office equipment		24,319			22,780
Furniture and fixtures		18,218			17,379
		571,056			506,274
Accumulated depreciation		(268,105	)		(187,556	)
Total	$	302,951		$	318,718

XML 37 R24.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

12 Months Ended

Aug. 31, 2017

Debt Disclosure [Abstract]

Schedule of Notes Payable

Notes payable at August 31, 2017 and 2016 consisted of the following:

	2017			2016
Notes payable to five individuals; accrues interest at 12% per annum; secured by assets of the Company; due May 29, 2016. These notes were fully repaid.	$	-		$	91,439

Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017.		7,134			47,636

Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.		399,400			-

Notes payable to financial institution; accrues interest at 6% per annum; monthly principal and interest payment of $608; unsecured; due April 8, 2019.		20,988			20,022
		427,522			159,097
Current portion		(13,171	)		(147,517	)
Long-term portion	$	414,351		$	11,580

Schedule of Future Maturities of Notes Payable

Aggregate future maturities of notes payable as of August 31, 2017 are as follows:

Years ending August 31:
2018	$	13,171
2019		414,351
	$	427,522

XML 38 R25.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Tables)

12 Months Ended

Aug. 31, 2017

Equity [Abstract]

Schedule of Stock Option and Warrant Activity

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2016		-
Transfer from reverse merger transactions		6,610,000	$	0.24
Granted		1,250,000	$	0.42
Forfeited		-
Exercised		-
Outstanding, August 31, 2017		7,860,000	$	0.266		3.53	$	660,000
Exercisable, August 31, 2017		6,860,000	$	0.258		3.34	$	660,000

Schedule of Options and Warrants Outstanding and Exercisable

The exercise price for options/warrants outstanding at August 31, 2017:

Outstanding				Exercisable
Number of				Number of
Options/		Exercise		Options/		Exercise
Warrants		Price		Warrants		Price
	5,500,000	$	0.16		5,500,000	$	0.16
	1,000,000		0.32		-		0.32
	100,000		0.50		100,000		0.50
	1,000,000		0.62		1,000,000		0.62
	250,000		0.80		250,000		0.80
	10,000		2.00		10,000		2.00
	7,860,000				6,860,000

Schedule of Fair Value of Options Granted by Using Valuation Assumptions

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate		1.5%
Expected life of the options		2.5 years
Expected volatility		323%
Expected dividend yield		0%

XML 39 R26.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

12 Months Ended

Aug. 31, 2017

Income Tax Disclosure [Abstract]

Schedule of Income Tax Expense

Income tax expense for the years ended August 31, 2017 and 2016 is a follows:

	2017		2016

Current taxes:
Federal	$	-	$	-
State		-		-
Foreign		111,702		-
		111,702		-
Deferred taxes:
Federal		-		-
State		-		-
Foreign		-		-
		-		-

Total income tax expense	$	111,702	$	-

Schedule of Effective and Statutory Income Tax Rates

A reconciliation of the differences between the effective and statutory income tax rates are as follows:

Year Ended August 31, 2017

	Canada					United States					Total

Combined statutory tax rate				39.0	%				40.0	%

Pretax loss	$	(257,900	)			$	(375,662	)			$	(699,551	)

Expected income tax expense (benefit)		(100,581	)	-39.0	%		(150,265	)	-40.0	%		(276,582	)
Income tax from subsidiaries not part of consolidated return		111,702		43.3	%		-		0.0	%		111,702
Stock based compensation		-		0.0	%		100,971		26.9	%		100,971
Change in valuation allowance		100,581		39.0	%		49,294		13.1	%		175,611
	$	111,702		43.3	%	$	-		0.0	%	$	111,702		17.6	%

Year Ended August 31, 2016

	Canada					United States				Total

Combined statutory tax rate				39.0	%			40.0	%

Pretax loss	$	(346,178	)			$	-			$	(346,178	)

Expected income tax expense (benefit)		(135,009	)	-39.0	%						(135,009	)
Change in valuation allowance		135,009		39.0	%						135,009
	$	-		0.0	%	$	-	0.0	%	$	-		0.0	%

Schedule of the Deferred Tax Assets

At August 31, 2017 and 2016, the significant components of the deferred tax assets are summarized below:

	2017			2016
Deferred income tax asset
Net operating loss carryforwards	$	1,856,218		$	1,391,467
Total deferred income tax asset		1,856,218			1,391,467
Less: valuation allowance		(1,856,218	)		(1,391,467	)
Total deferred income tax asset	$	-		$	-

XML 40 R27.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

12 Months Ended

Aug. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Annual Payments Under Operating Lease

Future minimum annual payments under operating lease agreements for fiscal years ending August 31 are as follows:

Years ending August 31:
2018	$	377,830
2019		292,778
2020		187,985
2021		169,376
2022		108,793
Thereafter		54,902
	$	1,191,664

XML 41 R28.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Details Narrative) - USD ($)		12 Months Ended
	Apr. 25, 2017	Aug. 31, 2017
Common stock issued in connection with reverse merger transaction		$ 6,904
Turbine Truck Engines, Inc [Member]
State country name		Delaware
Date of incorporation		Nov. 27, 2000
Turbine Truck Engines, Inc One [Member]
State country name		State of Nevada
Date of incorporation		Feb. 20, 2008
NHL [Member] \| Share Exchange Agreement [Member]
Number of restricted shares of common stock	167,797,406
Percentage of common stock issued and outstanding	85.00%

XML 42 R29.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) - CAD [Member]	Aug. 31, 2017	Aug. 31, 2016
Period End [Member]
Foreign currency exchange rate	0.7988	0.7620
Average Period [Member]
Foreign currency exchange rate	0.7573	0.7543

XML 43 R30.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Allowance for uncollectible accounts receivable	$ 507,636	$ 508,161
Goodwill	399,400
Acquisition deposits	$ 1,162,009
Potentially dilutive common stock options and warrants outstanding, shares	7,860,000
Gain on foreign currency transactions	$ 1,240,844	$ 1,277,449
Novo Healthnet Kemptville Centre, Inc [Member]
Equity method investment, ownership percentage	80.00%

XML 44 R31.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)	12 Months Ended
	Aug. 31, 2017
Leasehold Improvements [Member]
Property and equipment, estimated lives	5 years
Clinical Equipment [Member]
Property and equipment, estimated lives	5 years
Computer Equipment [Member]
Property and equipment, estimated lives	3 years
Office Equipment [Member]
Property and equipment, estimated lives	5 years
Furniture and Fixtures [Member]
Property and equipment, estimated lives	5 years

XML 45 R32.htm IDEA: XBRL DOCUMENT

Other Receivables - Schedule of Other Receivables (Details) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Total other receivables	$ 372,024	$ 735,330
Notes Receivable Dated November 15, 2014 [Member]
Total other receivables	39,940	38,099
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]
Total other receivables	299,550	285,750
Advance to Corporation One [Member]
Total other receivables		381,000
Advance to Corporation Two [Member]
Total other receivables	$ 32,534	$ 30,481

XML 46 R33.htm IDEA: XBRL DOCUMENT

Other Receivables - Schedule of Other Receivables (Details) (Parenthetical)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Notes Receivable Dated November 15, 2014 [Member]
Percentage of accrues interest per annum	8.00%	8.00%
Notes receivable due date	Nov. 15, 2016	Nov. 15, 2016
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]
Percentage of accrues interest per annum	12.00%	12.00%
Notes receivable due date	May 23, 2018	May 23, 2018

XML 47 R34.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 67,776	$ 72,586

XML 48 R35.htm IDEA: XBRL DOCUMENT

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Furniture and equipment, gross	$ 571,056	$ 506,274
Accumulated depreciation	(268,105)	(187,556)
Total	302,951	318,718
Leasehold Improvements [Member]
Furniture and equipment, gross	329,985	310,111
Clinical Equipment [Member]
Furniture and equipment, gross	177,514	147,429
Computer Equipment [Member]
Furniture and equipment, gross	21,020	8,575
Office Equipment [Member]
Furniture and equipment, gross	24,319	22,780
Furniture and Fixtures [Member]
Furniture and equipment, gross	$ 18,218	$ 17,379

XML 49 R36.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Notes Payable (Details) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Note payable	$ 427,522	$ 159,097
Current portion	(13,171)	(147,517)
Long-term portion	414,351	11,580
Note Payable One [Member]
Note payable		91,439
Note Payable Two [Member]
Note payable	7,134	47,636
Note Payable Three [Member]
Note payable	399,400
Note Payable Four [Member]
Note payable	$ 20,988	$ 20,022

XML 50 R37.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Notes payable, due date	Sep. 30, 2016
Note Payable One [Member]
Percentage of accrues interest per annum	12.00%	12.00%
Notes payable, due date	May 29, 2016	May 29, 2016
Note Payable Two [Member]
Percentage of accrues interest per annum	7.20%	7.20%
Notes payable, due date	Oct. 31, 2017	Oct. 31, 2017
Debt periodic payment	$ 3,567	$ 3,567
Note Payable Three [Member]
Percentage of accrues interest per annum	0.00%	0.00%
Notes payable, due date	Mar. 21, 2019	Mar. 21, 2019
Note Payable Four [Member]
Percentage of accrues interest per annum	6.00%	6.00%
Notes payable, due date	Apr. 08, 2019	Apr. 08, 2019
Debt periodic payment	$ 608	$ 608

XML 51 R38.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Future Maturities of Notes Payable (Details)	Aug. 31, 2017 USD ($)
Debt Disclosure [Abstract]
2018	$ 13,171
2019	414,351
Total	$ 427,522

XML 52 R39.htm IDEA: XBRL DOCUMENT

Debentures, Related Parties (Details Narrative)	12 Months Ended
Debentures, Related Parties (Details Narrative)	Aug. 31, 2017 USD ($)	Aug. 31, 2017 CAD	Aug. 31, 2016 USD ($)	Sep. 30, 2013 USD ($)
Debentures, related parties			$ 4,878,714
Debt interest rate	8.00%	8.00%
Debt due date	Sep. 30, 2016
Debt conversion description	The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
December 2, 2017 [Member]
Debt extended due date	Sep. 30, 2019
December 5, 2017 [Member] \| Maximum [Member]
Debt interest rate	75.00%	75.00%
Five Debentures [Member]
Debentures, related parties				$ 5,114,327
Five Debentures [Member] \| CAD [Member]
Debentures, related parties \| CAD		CAD 6,402,512

XML 53 R40.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit (Details Narrative) - USD ($)		12 Months Ended
Stockholders’ Deficit (Details Narrative) - USD ($)	Sep. 08, 2015	Aug. 31, 2017	Aug. 31, 2016
Convertible Preferred stock shares authorized		1,000,000	1,000,000
Convertible Preferred stock par value		$ 0.001	$ 0.001
Convertible Preferred stock shares issued		0	0
Convertible Preferred stock shares outstanding		0	0
Common stock shares authorized		499,000,000	499,000,000
Common stock par value		$ 0.001	$ 0.001
Common stock shares issued		201,837,254	167,797,406
Common stock shares outstanding		201,837,254	167,797,406
Common stock shares issued in connection with reverse merger transaction		22,751,307
Common stock shares issued for cash		11,288,541
Proceeds from issuance of common stock		$ 3,386,560
Stock options granted weighted-average grant date fair value		$ 0.58
Stock options/warrants weighted-average exercise		$ 0.42
Stock option expense		$ 252,428
Unamortized stock option expense		$ 381,585
2015 Incentive Compensation Plan [Member]
Number of shares issued for granted		4,987,500
2015 Incentive Compensation Plan [Member] \| Maximum [Member]
Number of common stock shares issued	5,000,000

XML 54 R41.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details)	12 Months Ended
	Aug. 31, 2017 USD ($) $ / shares shares
Equity [Abstract]
Options/Warrants Outstanding, Beginning balance
Options/Warrants Outstanding, Transfer from reverse merger transactions	6,610,000
Options/Warrants Outstanding, Granted	1,250,000
Options/Warrants Outstanding, Forfeited
Options/Warrants Outstanding, Exercised
Options/Warrants Outstanding, Ending balance	7,860,000
Options/Warrants Outstanding, Exercisable	6,860,000
Weighted Average Exercise Price, Beginning balance \| $ / shares
Weighted Average Exercise Price, Transfer from reverse merger transactions \| $ / shares	0.24
Weighted Average Exercise Price, Granted \| $ / shares	0.42
Weighted Average Exercise Price, Ending balance \| $ / shares	0.266
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 0.258
Weighted Average Remaining Contractual Life, Outstanding	3 years 6 months 10 days
Weighted Average Remaining Contractual Life, Exercisable	3 years 4 months 2 days
Aggregate Intrinsic Value, Outstanding \| $	$ 660,000
Aggregate Intrinsic Value, Exercisable \| $	$ 660,000

XML 55 R42.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details)	Aug. 31, 2017 $ / shares shares
Number of Options/Warrants, Outstanding	7,860,000
Number of Options/Warrants, Exercisable	6,860,000
Exercise Price Range One [Member]
Number of Options/Warrants, Outstanding	5,500,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.16
Number of Options/Warrants, Exercisable	5,500,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.16
Exercise Price Range Two [Member]
Number of Options/Warrants, Outstanding	1,000,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.32
Number of Options/Warrants, Exercisable
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.32
Exercise Price Range Three [Member]
Number of Options/Warrants, Outstanding	100,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.50
Number of Options/Warrants, Exercisable	100,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.50
Exercise Price Range Four [Member]
Number of Options/Warrants, Outstanding	1,000,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.62
Number of Options/Warrants, Exercisable	1,000,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.62
Exercise Price Range Five [Member]
Number of Options/Warrants, Outstanding	250,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.80
Number of Options/Warrants, Exercisable	250,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.80
Exercise Price Range Six [Member]
Number of Options/Warrants, Outstanding	10,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 2.00
Number of Options/Warrants, Exercisable	10,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 2.00

XML 56 R43.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details)	12 Months Ended
	Aug. 31, 2017
Equity [Abstract]
Risk-free interest rate	1.50%
Expected life of the options	2 years 6 months
Expected volatility	323.00%
Expected dividend yield	0.00%

XML 57 R44.htm IDEA: XBRL DOCUMENT

Income Taxes (Details Narrative) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Valuation allowance	$ 464,751	$ 132,876
Deferred tax valuation allowance	1,856,218	1,391,467
Unrecognized tax benefits
United States [Member]
Net operating loss carry-forwards	738,000
Canada [Member]
Net operating loss carry-forwards	$ 3,887,000

XML 58 R45.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Income Tax Disclosure [Abstract]
Current taxes, Federal
Current taxes, State
Current taxes, Foreign	111,702
Current taxes total	111,702
Deferred taxes, Federal
Deferred taxes, State
Deferred taxes, Foreign
Deferred taxes total
Total income tax expense	$ 111,702

XML 59 R46.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Effective and Statutory Income Tax Rates (Details) - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Pretax loss	$ (699,551)	$ (346,178)
Expected income tax expense (benefit)	(276,582)	(135,009)
Income tax from subsidiaries not part of consolidated return	111,702
Stock based compensation	100,971
Change in valuation allowance	175,611	135,009
Total	$ 111,702
Total, percent	17.60%	0.00%
Canada [Member]
Pretax loss	$ (257,900)	$ (346,178)
Expected income tax expense (benefit)	(100,581)	(135,009)
Income tax from subsidiaries not part of consolidated return	111,702
Stock based compensation
Change in valuation allowance	100,581	135,009
Total	$ 111,702
Combined statutory tax rate	39.00%	39.00%
Expected income tax expense (benefit), percent	(39.00%)	(39.00%)
Income tax from subsidiaries not part of consolidated return, percent	43.30%
Stock based compensation, percent	0.00%
Change in valuation allowance, percent	39.00%	39.00%
Total, percent	43.30%	0.00%
United States [Member]
Pretax loss	$ (375,662)
Expected income tax expense (benefit)	(150,265)
Income tax from subsidiaries not part of consolidated return
Stock based compensation	100,971
Change in valuation allowance	49,294
Total
Combined statutory tax rate	40.00%	40.00%
Expected income tax expense (benefit), percent	(40.00%)
Income tax from subsidiaries not part of consolidated return, percent	0.00%
Stock based compensation, percent	26.90%
Change in valuation allowance, percent	13.10%
Total, percent	0.00%	0.00%

XML 60 R47.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of the Deferred Tax Assets (Details) - USD ($)	Aug. 31, 2017	Aug. 31, 2016
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 1,856,218	$ 1,391,467
Total deferred income tax asset	1,856,218	1,391,467
Less: valuation allowance	(1,856,218)	(1,391,467)
Total deferred income tax asset

XML 61 R48.htm IDEA: XBRL DOCUMENT

Acquisition of Assets (Details Narrative)	12 Months Ended
Acquisition of Assets (Details Narrative)	Aug. 31, 2017 USD ($)	Aug. 31, 2017 CAD	Aug. 31, 2016 USD ($)
Note payable issued for purchase of assets \| $	$ 399,400
CAD [Member]
Note payable issued for purchase of assets \| CAD		CAD 500,000

XML 62 R49.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Aug. 31, 2017	Aug. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Operating leases expiration date	2023
Rent expense	$ 796,745	$ 763,339

XML 63 R50.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Future Minimum Annual Payments Under Operating Lease (Details)	Aug. 31, 2017 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2018	$ 377,830
2019	292,778
2020	187,985
2021	169,376
2022	108,793
Thereafter	54,602
Total	$ 1,191,664

XML 64 R51.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative)					12 Months Ended
Subsequent Events (Details Narrative)	Dec. 05, 2017	Dec. 02, 2017 USD ($)	Dec. 01, 2017 USD ($) shares	Sep. 18, 2017 $ / shares shares	Aug. 31, 2017 USD ($) $ / shares shares	Dec. 02, 2017 CAD	Aug. 31, 2017 CAD	Aug. 31, 2016 USD ($)	Sep. 30, 2013 USD ($)
Number of option granted shares issued					1,250,000
Stock option exercise price \| $ / shares					$ 0.42
Debentures, related parties \| $								$ 4,878,714
Debt due date					Sep. 30, 2016
Debt interest rate					8.00%		8.00%
Debt conversion description					The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Five Debentures [Member]
Debentures, related parties \| $									$ 5,114,327
Five Debentures [Member] \| CAD [Member]
Debentures, related parties \| CAD							CAD 6,402,512
Subsequent Event [Member]
Number of option granted shares issued				120,000
Stock option exercise price \| $ / shares				$ 0.40
Number of option vested				60,000
Number of restricted shares issued			384,110
Number of restricted shares issued value \| $			$ 233,155
Debt due date		Sep. 30, 2016
Debt extended due date		Sep. 30, 2019
Debt interest rate	75.00%
Debt conversion description	The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Subsequent Event [Member] \| Five Debentures [Member]
Debentures, related parties \| $		$ 5,114,327
Subsequent Event [Member] \| Five Debentures [Member] \| CAD [Member]
Debentures, related parties \| CAD						CAD 6,402,512
Subsequent Event [Member] \| March 18, 2018 [Member]
Number of option vested					60,000

EXCEL 65 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 67 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 115 233 1 false 42 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://novointegrated.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://novointegrated.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://novointegrated.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://novointegrated.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Deficit Sheet http://novointegrated.com/role/StatementOfStockholdersDeficit Consolidated Statement of Stockholders' Deficit Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://novointegrated.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Basis of Presentation Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Related Party Transactions Sheet http://novointegrated.com/role/RelatedPartyTransactions Related Party Transactions Notes 9 false false R10.htm 00000010 - Disclosure - Other Receivables Sheet http://novointegrated.com/role/OtherReceivables Other Receivables Notes 10 false false R11.htm 00000011 - Disclosure - Property and Equipment Sheet http://novointegrated.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Notes Payable Notes http://novointegrated.com/role/NotesPayable Notes Payable Notes 12 false false R13.htm 00000013 - Disclosure - Debentures, Related Parties Sheet http://novointegrated.com/role/DebenturesRelatedParties Debentures, Related Parties Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' Deficit Sheet http://novointegrated.com/role/StockholdersDeficit Stockholders' Deficit Notes 14 false false R15.htm 00000015 - Disclosure - Income Taxes Sheet http://novointegrated.com/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 00000016 - Disclosure - Acquisition of Assets Sheet http://novointegrated.com/role/AcquisitionOfAssets Acquisition of Assets Notes 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies Sheet http://novointegrated.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://novointegrated.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Organization and Basis of Presentation (Tables) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables Organization and Basis of Presentation (Tables) Tables http://novointegrated.com/role/OrganizationAndBasisOfPresentation 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Other Receivables (Tables) Sheet http://novointegrated.com/role/OtherReceivablesTables Other Receivables (Tables) Tables http://novointegrated.com/role/OtherReceivables 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://novointegrated.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://novointegrated.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Notes Payable (Tables) Notes http://novointegrated.com/role/NotesPayableTables Notes Payable (Tables) Tables http://novointegrated.com/role/NotesPayable 24 false false R25.htm 00000025 - Disclosure - Stockholders' Deficit (Tables) Sheet http://novointegrated.com/role/StockholdersDeficitTables Stockholders' Deficit (Tables) Tables http://novointegrated.com/role/StockholdersDeficit 25 false false R26.htm 00000026 - Disclosure - Income Taxes (Tables) Sheet http://novointegrated.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://novointegrated.com/role/IncomeTaxes 26 false false R27.htm 00000027 - Disclosure - Commitments and Contingencies (Tables) Sheet http://novointegrated.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://novointegrated.com/role/CommitmentsAndContingencies 27 false false R28.htm 00000028 - Disclosure - Organization and Basis of Presentation (Details Narrative) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationDetailsNarrative Organization and Basis of Presentation (Details Narrative) Details http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables 28 false false R29.htm 00000029 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation-ScheduleOfForeignCurrencyTranslationExchangeRateUsedDetails Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Details 29 false false R30.htm 00000030 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEstimatedUsefulLivesOfAssetsDetails Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Details 31 false false R32.htm 00000032 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetails Other Receivables - Schedule of Other Receivables (Details) Details 32 false false R33.htm 00000033 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetailsParenthetical Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Details 33 false false R34.htm 00000034 - Disclosure - Property and Equipment (Details Narrative) Sheet http://novointegrated.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://novointegrated.com/role/PropertyAndEquipmentTables 34 false false R35.htm 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://novointegrated.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 35 false false R36.htm 00000036 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetails Notes Payable - Schedule of Notes Payable (Details) Details 36 false false R37.htm 00000037 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetailsParenthetical Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Details 37 false false R38.htm 00000038 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfFutureMaturitiesOfNotesPayableDetails Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Details 38 false false R39.htm 00000039 - Disclosure - Debentures, Related Parties (Details Narrative) Sheet http://novointegrated.com/role/DebenturesRelatedPartiesDetailsNarrative Debentures, Related Parties (Details Narrative) Details http://novointegrated.com/role/DebenturesRelatedParties 39 false false R40.htm 00000040 - Disclosure - Stockholders’ Deficit (Details Narrative) Sheet http://novointegrated.com/role/StockholdersDeficitDetailsNarrative Stockholders’ Deficit (Details Narrative) Details 40 false false R41.htm 00000041 - Disclosure - Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfStockOptionAndWarrantActivityDetails Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfOptionsAndWarrantsOutstandingAndExercisableDetails Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Details 42 false false R43.htm 00000043 - Disclosure - Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfFairValueOfOptionsGrantedByUsingValuationAssumptionsDetails Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Details 43 false false R44.htm 00000044 - Disclosure - Income Taxes (Details Narrative) Sheet http://novointegrated.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://novointegrated.com/role/IncomeTaxesTables 44 false false R45.htm 00000045 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Details) Sheet http://novointegrated.com/role/IncomeTaxes-ScheduleOfIncomeTaxExpenseDetails Income Taxes - Schedule of Income Tax Expense (Details) Details 45 false false R46.htm 00000046 - Disclosure - Income Taxes - Schedule of Effective and Statutory Income Tax Rates (Details) Sheet http://novointegrated.com/role/IncomeTaxes-ScheduleOfEffectiveAndStatutoryIncomeTaxRatesDetails Income Taxes - Schedule of Effective and Statutory Income Tax Rates (Details) Details 46 false false R47.htm 00000047 - Disclosure - Income Taxes - Schedule of the Deferred Tax Assets (Details) Sheet http://novointegrated.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails Income Taxes - Schedule of the Deferred Tax Assets (Details) Details 47 false false R48.htm 00000048 - Disclosure - Acquisition of Assets (Details Narrative) Sheet http://novointegrated.com/role/AcquisitionOfAssetsDetailsNarrative Acquisition of Assets (Details Narrative) Details http://novointegrated.com/role/AcquisitionOfAssets 48 false false R49.htm 00000049 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://novointegrated.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://novointegrated.com/role/CommitmentsAndContingenciesTables 49 false false R50.htm 00000050 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Annual Payments Under Operating Lease (Details) Sheet http://novointegrated.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumAnnualPaymentsUnderOperatingLeaseDetails Commitments and Contingencies - Schedule of Future Minimum Annual Payments Under Operating Lease (Details) Details 50 false false R51.htm 00000051 - Disclosure - Subsequent Events (Details Narrative) Sheet http://novointegrated.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://novointegrated.com/role/SubsequentEvents 51 false false All Reports Book All Reports nvos-20170831.xml nvos-20170831.xsd nvos-20170831_cal.xml nvos-20170831_def.xml nvos-20170831_lab.xml nvos-20170831_pre.xml http://xbrl.sec.gov/currency/2017-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 71 0001493152-17-014422-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-17-014422-xbrl.zip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end